[Link]
http://crossmark.crossref.org/dialog/?doi=10.1016/j.pneurobio.2013.10.003&domain=pdf
[Link]
http://crossmark.crossref.org/dialog/?doi=10.1016/j.pneurobio.2013.10.003&domain=pdf
[Link]
http://dx.doi.org/10.1016/j.pneurobio.2013.10.003
[Link]
mailto:cbduarte@ci.uc.pt
[Link]
http://www.sciencedirect.com/science/journal/03010082
[Link]
http://dx.doi.org/www.elsevier.com/locate/pneurobio
[Link]
http://dx.doi.org/10.1016/j.pneurobio.2013.10.003
Role of the ubiquitin–proteasome system in brain ischemia: Friend or
foe?
Margarida V. Caldeiraa,b,1, Ivan L. Salazara,c,d,1, Michele Curcioa,e,1,
Lorella M.T. Canzonieroe, Carlos B. Duartea,b,*
aCNC—Center for Neuroscience and Cell Biology, University of Coimbra, Largo Marque ˆs de Pombal, 3004-517 Coimbra, Portugal
bDepartment of Life Sciences, University of Coimbra, 3004-517 Coimbra, Portugal
cDoctoral Programme in Experimental Biology and Biomedicine, Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
dInstitute for Interdisciplinary Research, University of Coimbra (IIIUC), Portugal
eDepartment of Science and Technology, University of Sannio, Benevento, Italy
A R T I C L E I N F O
Article history:
Received 14 June 2013
Received in revised form 8 October 2013
Accepted 15 October 2013
Available online 22 October 2013
Keywords:
Ubiquitin–proteasome system
Brain ischemia
Excitotoxicity
Proteasome inhibitors
A B S T R A C T
Theubiquitin–proteasomesystem(UPS)isacatalyticmachinerythattargetsnumerouscellularproteins
fordegradation,thusbeingessentialtocontrolawiderangeofbasiccellularprocessesandcellsurvival.
DegradationofintracellularproteinsviatheUPSisatightlyregulatedprocessinitiatedbytaggingatarget
protein with a specific ubiquitin chain. Neurons are particularly vulnerable to any change in protein
composition,andthereforetheUPSisakeyregulatorofneuronal physiology.AlterationsinUPS activity
may induce pathological responses, ultimately leading to neuronal cell death. Brain ischemia triggers a
complex series of biochemical and molecular mechanisms, such as an inflammatory response, an
exacerbatedproductionofmisfoldedandoxidizedproteins,duetooxidativestress,andthebreakdownof
cellular integrity mainly mediated by excitotoxic glutamatergic signaling. Brain ischemia also damages
protein degradation pathways which, together with the overproduction of damaged proteins and
consequent upregulationofubiquitin-conjugatedproteins,contribute totheaccumulation of ubiquitincontaining proteinaceous deposits. Despite recent advances, the factors leading to deposition of such
aggregates after cerebral ischemic injury remain poorly understood. This review discusses the current
knowledge on the role of the UPS in brain function and the molecular mechanisms contributing to UPS
dysfunctioninbrainischemiawithconsequentaccumulationofubiquitin-containingproteins.Chemical
inhibitorsoftheproteasomeandsmallmoleculeinhibitorsofdeubiquitinatingenzymes,whichpromote
the degradation of proteins by the proteasome, were both shown to provide neuroprotection in brain
ischemia, and this apparent contradiction is also discussed in this review.
 2013 Elsevier Ltd. All rights reserved.
Progress in Neurobiology 112 (2014) 50–69
Abbreviations: 3-MA, 3-methyladenine; 15d-PHJ
2
, 15-deoxy-D12,14-prostaglandin J2; AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid; AMPAR, AMPA
receptors; APC/C, anaphase-promoting complex/cyclosome; APV, D-aminophosphonovalerate; ATF4, activating transcription factor 4; axJ, ataxic mouse; BBB, blood–brain
barrier;BCO,bilateralcarotidocclusion;[Ca2+]i,intracellularCa2+concentration;Cdk5,cyclin-dependentkinase-5;CHOP,C/EBPhomologuesprotein;CP,catalyticparticle;
DUB, deubiquitinating enzymes; eIF2a, eukaryotic initiation factor 2a; ER, endoplasmic reticulum; ERAD, ER-associated degradation; GKAP, guanylate kinase-associated
protein; GRP78, glucose-regulated protein 78; HECT, E6-AP carboxyl terminus; HERP, homocysteine-inducible, ER-stress inducible protein; KA, kainate; MARKS,
myristoylated, alanine-rich C-kinase substrate; MCAO, middle cerebral artery occlusion; Mdm2, murine-double minute 2; mESPC, mini excitatory post-synaptic current;
NCX3, sodium–calcium exchanger type-3; Mib2, Mind Bomb-2; Nedd4, neuronal-precursor cell-expressed developmentally downregulated gene 4; NMDA, N-methyl-D-
aspartate; NMDAR, NMDA receptors; NOS, nitric oxide synthase; eNOS, endothelial NOS; OGD, oxygen and glucose deprivation; PDI, protein disulphide isomerase; PERK,
PKR-likeERkinase;PI3K,phosphoinositide3-kinase;Pru,pleckstrin-likereceptorforubiquitin;PSD,post-synapticdensity;PSD-95,post-synapticdensityassociatedprotein
95; RING, really interesting new gene; RP, regulatory particle; tPA, tissue plasminogen activator; TRPM, transient receptor potential melastatin; UBA, ubiquitin associated
domain; UBL, ubiquitin-like domain; UCH, ubiquitin C-terminal hydrolases; UIM, ubiquitin-interacting motif; UPR, unfolded protein response; UPS, ubiquitin–proteasome
system; USP, ubiquitin specific protease; VGLUT, vesicular glutamate transporters; XBP1, X-box binding protein 1.
* Correspondingauthorat:CenterforNeuroscienceandCellBiology,UniversityofCoimbra,LargoMarquesdePombal,3004-517Coimbra,Portugal.Tel.:+351304502910;
fax: +351 239 822 776.
E-mail address: cbduarte@ci.uc.pt (C.B. Duarte).
1 These authors contributed equally to this work.
Contents lists available at ScienceDirect
Progress in Neurobiology
journal homepage: www.elsevier.com/locate/pneurobio
0301-0082/$ – see front matter 2013 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.pneurobio.2013.10.003
(TRIAL VER. PDF Extractor SDK 8.0.0.2542.1585534813)
Contents
1. Brain ischemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
1.1. Role of glutamate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
1.2. Intracellular calcium overload . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
1.3. Endoplasmic reticulum (ER) stress in brain ischemia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
1.4. Autophagy in brain ischemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2. UPS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2.1. Ubiquitin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2.2. Ubiquitination machinery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.3. Deubiquitinating enzymes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
2.4. Proteasome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
2.5. Immunoproteasome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3. Role of UPS in nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4. UPS in ischemic conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.1. UPS and in vivo ischemia models. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2. Changes in the UPS in in vitro models of global ischemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.3. UPS in glutamate-induced excitotoxicity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.4. UPS in ischemic tolerance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.5. Protective effects of proteasome modulators in brain ischemia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
1. Brain ischemia
Brain ischemia is a leading cause of death and disability
worldwide, resulting from a reduction in the blood flow to the
brain. This leads to a deprivation of oxygen and glucose, and cell
deathisthefatalendcausedbythereductionofthefuelsavailable
for the metabolism of the cells. Brain ischemia may be caused by
cardiac arrest (global ischemia, affecting the entire brain) or by
ischemic stroke (focal ischemia, which targets a specific brain
region).
Ischemic stroke occurs as a result of the occlusion of a blood
vessel supplying blood to the brain by a thrombus or an embolus
(Doyleetal.,2008;Rogeretal.,2012).Inthiscondition,theregion
ofthebrainthatismostdamaged,theischemiccore,fullydepends
onoxygenandglucoseprovidedbytheaffectedbloodvessel,while
the penumbra region, the area surrounding the infarcted core, is
not as compromised due to a limited supply of components
required for the metabolism derived from the collateral circulation. Glucose is the main substrate for cerebral energy production
(Hofmeijer and van Putten, 2012) and during stroke the oxygen
carried by the blood is much less than that required for complete
oxidation of its content of glucose. Under these conditions,
glycolysis may persist after oxygen has been depleted, but the
reduction of oxidative metabolism of glucose leads to decreased
ATP levels, while ADP and AMP levels increase (Hertz, 2008),
causingadisruptionofionichomeostasis(Hansen,1985),opening
of anion channels (Kimelberg and Mongin, 1998), plasma
membrane depolarization (Lipton, 1999), release of glutamate
through astrocytic hemichannels (Ye et al., 2003) and downregulation of glutamate transporters (Harvey et al., 2011). The
impairment of glutamate transporters, in addition to their
operation in the reverse mode, leads to an accumulation of
glutamate in the extracellular space (Grewer et al., 2008) and a
consequent overactivation of postsynaptic glutamate receptors.
Under these conditions, necrotic cell death occurs at the core
region,whileinthepenumbraregiontheavailabilityofATPallows
a delayed cell death by apoptosis (Broughton et al., 2009).
The hippocampus is particularly vulnerable to brain ischemia,
but distinct responses are typically observed in the different
hippocampal subregions. The CA1 region is highly sensitive to
transient ischemia followed by reperfusion, but this neuronal
population die far later after ischemic insult, a process referred to
as delayed neuronal death (Kirino, 1982; Pulsinelli et al., 1982a).
Thisisauniquetypeofcelldeaththatprogressesdespitecomplete
recovery of metabolic parameters, such as regional blood flow,
glucose metabolism and tissue ATP content (Kirino, 1982;
Pulsinelli et al., 1982b; Mies et al., 1990), but the molecular
mechanisms involved are yet to be clearly understood.
1.1. Role of glutamate
Duringstroke,membranedepolarizationduetoATPbreakdown
leads to an increase in the release of glutamate, and the lack of
energy blocks the reuptake of the excitatory amino acids at the
synapse, leading to an extracellular accumulation of glutamate
(Rossi et al., 2000; Grewer et al., 2008). The reversal of the
glutamate transporters under these conditions (Rossi et al., 2000;
Grewer et al., 2008) further contributes to the extracellular
accumulationofglutamate,withaconsequenttoxicoveractivation
ofpostsynapticglutamate receptors(excitotoxicity)(Olney, 1969;
Simon et al., 1984; Choi et al., 1987; Ferreira et al., 1996, 1998;
Marteletal.,2012).Uponoxygenandglucosedeprivation(OGD),a
well established in vitro model of global ischemia, glutamate is
massively released by neurons, and the resulting increase in the
intracellularCa2+concentration([Ca2+]
i
)(GoldbergandChoi,1993)
causes a delayed neuronal cell death (calcium overload hypothesis)
(Manev et al., 1989). Ca2+ uptake and neuronal cell death can be
prevented by the NMDA (N-methyl-D-aspartate) receptor
(NMDAR) antagonist D-aminophosphonovalerate (APV) (Goldberg
and Choi, 1993). In addition, the volume of microinfarcts induced
byocclusionsofindividualpenetratingarteriolesorvenulesinthe
rat brain cortex could be reduced by administrating memantine
30–45min after the occlusion, ameliorating perceptual deficits
(Shih et al., 2013). These data indicate that NMDAR, characterized
by their high Ca2+ permeability, are the link between glutamate,
Ca2+andneuronalcelldeath.Ontheotherhand,itwasshownthat
blocking NMDAR with MK-801 decreases the density of healthy
cells in the dentate gyrus (Gould et al., 1994), indicating that a
moderate flow of Ca2+ ions through NMDAR is beneficial for
neurons, while Ca2+ overload, linked with an excessive NMDAR
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 51
(BY PDF Extractor SDK TRIAL VERSION)
activation, is deleterious (NMDAR paradox) (Hardingham and
Bading, 2003).
Not all NMDAR contribute to neuronal cell death in excitotoxicity
,sincethesynapticandextrasynapticreceptorpopulations
aredifferentiallycoupledtotheactivationofintracellularsignaling
mechanisms: the latter receptors mediate the influx of calcium
ions leading to mitochondrial injury (Stanika et al., 2009),
activation of pro-apoptotic genes (Leveille et al., 2010), cleavage
of fodrin and the sodium–calcium exchanger type-3 (NCX3) by
calpains(Xuetal.,2009a),andcelldeath(Hardinghametal.,2002).
Ontheotherhand,activationofsynapticNMDARisnotcoupledto
hippocampalneurondamage(Hardinghametal.,2002),butrather
promotes resistance to oxidative insults and prevents accumulation of reactive oxygen species in cortical neurons (Papadia et al.,
2008) (Fig. 1). Furthermore, synaptic NMDA receptors induce
genomic alterations that render neurons more resistant to
apoptosis and oxidative insults (Hardingham et al., 2002; Leveille
et al., 2010; Kaufman et al., 2012; Karpova et al., 2013). However,
the relative role of synaptic and extrasynaptic NMDAR in
excitotoxic cell death needs further investigation, considering
the conflicting results showing neurotoxicity induced by synaptic
NMDAR (Papouin et al., 2012) and the evidence pointing to a role
for these receptors in hypoxic excitotoxic death (Wroge et al.,
2012).
In addition to the role played by NMDAR in neuronal death in
brain ischemia,AMPA(a-amino-3-hydroxy-5-methyl-4-isoxazole
proprionic acid) receptor (AMPAR) activity was also shown to
mediate ischemic stroke damage in hippocampal CA1 pyramidal
neurons (Soundarapandian et al., 2005). Exposure of hippocampal
neurons to a brief period of OGD promotes a redistribution of
AMPAR at the synapse, with internalization of synaptic GluA2-
containing AMPAR and synaptic delivery of AMPAR lacking GluA2
subunits, which are permeable to calcium and zinc (Liu et al.,
2006). In fact, activation of AMPAR was also shown to induce
calpain activation (Araujo et al., 2004), and AMPAR antagonists
provided neuroprotection in a model of in vivo ischemia (Sheardown et al., 1990; Noh et al., 2005). Taken together, these data
indicate that NMDAR may act together with AMPAR to induce
neuronal demise under excitotoxic conditions.
1.2. Intracellular calcium overload
The perfect gear that regulates Ca2+ efflux, intracellular Ca2+
buffering and intracellular Ca2+ storage is a neuronal feature that
maintainsalowintracellularcalciumconcentration([Ca2+]
i
)when
compared with the extracellular space (Sattler and Tymianski,
2000). Following ischemia, the [Ca2+]
i
can reachmM levels due to
thebreakdownofthesemechanismsandtheintracellularcalcium
overload is linked with overactivation of enzymes such as
proteases, phospholipases and endonucleases, with the resulting
breakdown of proteins, lipids and nucleic acids, and consequent
neuronal death (Coyle and Puttfarcken, 1993; Lee et al., 1999).
Calpains are a group of Ca2+-dependent proteases very well
characterized for their role in neurodegeneration. The excessive
Fig.1.Activationofionotropicglutamatereceptorsanddownstreamresponsesinbrainischemia.Theincreasedreleaseofglutamateandtheinhibitionofglutamateuptake
mechanisms in brain ischemia induces glutamate spillover from the synapse which overactivate iGluR. The downregulation of GluA2 mRNA and protein expression,
associated with the internalization of GluA2-containing AMPAR and synaptic delivery of Ca2+ permeable-AMPAR (lacking GluA2) observed in post-ischemic neurons
contributetotheincreasein[Ca2+]
i
(Tanakaetal.,2000;Liuetal.,2006).The[Ca2+]
i
overloadincreasescalpainactivitywithconsequentcleavageofseveralproteins,which
contributes to cell death (Araujo et al., 2004; Sanchez-Gomez et al., 2011). Calcium influx through synaptic NMDAR induces signaling pathways which upregulate the
transcriptionofanti-apoptoticgenesandgenesinvolvedinantioxidantdefenses(Hardinghametal.,2002;Leveilleetal.,2010;Kaufmanetal.,2012;Karpovaetal.,2013).In
contrast,theexcessiveactivationofextrasynapticNMDARinducessignalingpathwayspromotingtranscriptionofpro-apoptoticgenesandmitochondrialinjury,contributing
to excitotoxic cell death (Stanika et al., 2009; Leveille et al., 2010; Kaufman et al., 2012; Wroge et al., 2012). Moreover, extrasynaptic NMDAR activity induces calpainmediatedcleavageofMyocyteenhancerfactor2(MEF2),glutamicaciddecarboxylase(GAD65/67),Fodrin,NCX3,andSTEP(Xuetal.,2009a,b;Monnerieetal.,2010;Weietal.,
2012).
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 52
(TRIAL PDF Extractor SDK 8.0.0.2542-472792858)
activationofcalpainsbytheintracellularcalciumoverloadinbrain
ischemiaandinexcitotoxicconditions(Caminsetal.,2006;Bevers
and Neumar, 2008) leads to the cleavage of plasma membrane
proteins (Lu et al., 2000; Neumar et al., 2001; Rong et al., 2001;
Yuen et al., 2007; Gomes et al., 2012), synaptic vesicle proteins
(Gomes et al., 2011; Lobo et al., 2011), transporters (Bano et al.,
2005; Pottorf et al., 2006), mitochondrial proteins (Takano et al.,
2005) and many other substrates (Bevers and Neumar, 2008).
Lipases are also activated by calcium, further increasing the
production of free radical species (Farooqui and Horrocks, 1994).
The neuronal isoform of nitric oxide synthase (NOS) is also
activated by Ca2+ and ischemia-associated NO overproduction
perturbs ATP synthesis and induces the release of proteins
involved in cell death (Heales et al., 1999).
Besides the glutamate receptor-induced [Ca2+]
i
overload (see
above), other channels have been proposed to mediate Ca2+ influx
under excitotoxic conditions. The activation of transient receptor
potential melastatin (TRPM) channels, primarily the Ca2+-permeable TRPM2 (Lipski et al., 2006; Jia et al., 2011) and TRPM7
channels(Aartsetal.,2003;Sunetal.,2009),hasbeenassociatedto
oxidative stress, in addition to anoxic and ischemic cell death.
Anotherkeyeventduringstrokeisacidosis,causedbythedecrease
inthesupplyofoxygentothebrain,whichleadstocalciuminflux,
and failure of oxidative phosphorylation, with an increase in
lactate production and the switch to glycolytic metabolism, with
the final decrease in tissue pH (Xiong et al., 2004; Gu et al., 2010).
1.3. Endoplasmic reticulum (ER) stress in brain ischemia
Electron microscopy analysis of the ER and Golgi morphology
showed significant alterations following brain ischemia and
reperfusion, from ‘flattened pancake’ to ‘rounded vesicles’ (Petito
and Pulsinelli, 1984). From the functional point of view, brain
ischemia was shown to impair the sarcoplasmic/endoplasmic
reticulum Ca2+ ATPase, which is responsible for the accumulation
of Ca2+ into the ER (Kohno et al., 1997; Parsons et al., 1997, 1999).
The resulting depletion of Ca2+ in this compartment is known to
induce ER stress (e.g. Nakagawa et al., 2000). Pretreament with a
NO synthase inhibitor significantly reduced the depletion of Ca2+
from the ER in gerbils subjected to transient global cerebral
ischemia,suggestingthattheincreaseinNOproductionduringthe
early reperfusion period contributes to the loss in the Ca2+
bufferingcapacityoftheER(Kohnoetal.,1997).Oxidativedamage
of the ER during the reperfusion period is also likely to contribute
to the ER stress due to modifications induced in ER proteins
(Hayashi et al., 2003).
Under mild ER stress conditions the cells develop a protective
mechanism, named unfolded protein response (UPR), which is
mediated by induction of molecular chaperones in the ER,
downregulation of translation activity and enhancement of ER-
associated degradation pathways (ERAD). However, more aggressiveconditionsupregulatetheexpressionofproaptoptoticfactors,
includingCHOP(C/EBPhomologuesprotein)/GADD153,amember
of the C/EBP family of transcription factors, and caspase-12,
leadingtocelldeath(Fengetal.,2001;DeGraciaandMontie,2004;
Paschen and Mengesdorf, 2005; Boyce and Yuan, 2006).
Inhibition of translation in response to ER stress avoids the
synthesis of proteins that could not be properly folded and,
therefore, is thought to be protective. Translation inhibition in
transient cerebral ischemia correlates with the selective vulnerability of post-ischemic neurons, and may be partly due to a
transient activation of PKR-like ER kinase (PERK). This kinase
phosphorylatestheeIF2a(eukaryoticinitiationfactor2a)thereby
inhibiting the initiation step of protein synthesis (Kumar et al.,
2001,2003;Hayashietal.,2003,2004;Paschenetal.,2003;Nakka
etal.,2010).However,additionalmechanismsmayalsocontribute
totheinhibitionofproteinsynthesisaftertransientbrainischemia
(for more detailed discussion see: DeGracia and Montie, 2004;
DeGracia et al., 2008). mRNAs whose translation is normally
blockedby50 upstreamopen-readingframescanstillbetranslated
in the presence of the phosphorylated form of eIF2a (eukaryotic
initiation factor 2a) and this may explain the synthesis of specific
proteins in UPR. The mRNA coding for ATF4 (activating transcriptionfactor4)istranslatedbythismechanism(Hardingetal.,2000),
and the ATF4 transcription factor is known to contribute to chop
mRNA transcription (Ma et al., 2002). An upregulation of the chop
mRNA is a characteristic feature of ER stress and UPR activation,
andwasobservedinthestriatumandhippocampusaftertransient
bilateral occlusion of common carotid arteries (Tajiri et al., 2004),
as well as in other models of ischemia and reperfusion (Paschen
et al., 1998, 2003; Roberts et al., 2007; Nakka et al., 2010; Osada
etal.,2010).HippocampalneuronsfromCHOP/miceexhibiteda
significantly lower rate of cell death, when compared with wildtypeanimals,indicatingthattransientischemia-inducedcelldeath
is mediated by CHOP induction (Tajiri et al., 2004).
Caspase-12isanERproteasetypicallyactivatedunderERstress
conditions, and early studies showed a role for this caspase in ER-
stress induced cell death (e.g. Nakagawa et al., 2000). Caspase-12
activationwasdetectedintheischemicbrainat5hofreperfusion
after occlusion of the middle cerebral artery (MCAO), which was
accompanied by an increase in caspase-12 protein levels (Shibata
et al., 2003; Nakka et al., 2010). An upregulation of caspase-12
mRNA and protein was also found in the striatum and cerebral
cortex after permanent MCAO in rats (Mouw et al., 2003).
However, the role of this protease in neuronal demise in the
ischemic brain remains to be determined. In fact, it was proposed
that caspase-12 acts mainly as a dominant negative in the
regulationofcaspase-1activityandthemainroleoftheproteolytic
activity of caspase-12 may be in the processing of the protease
(Roy et al., 2008).
Adistinctmechanisminvolvedinthealterationoftranscription
activity during the UPR is mediated by activation of the
endonuclease IRE1, which processes the mRNA for XBP1 (X-box
binding protein 1) (Yoshida et al., 1998; Calfonet al., 2002).These
mRNAs are translated in a processed XBP1 protein (XBP1proc)
which is translocated to the nucleus, serving as a transcription
factor that induces the expression of ER genes, such as grp78 and
grp94 (Calfon et al., 2002). Although the xbp1 mRNA was found to
be processed early after reperfusion following global and focal
ischemia, a delayed increase in XBP1proc was only observed in the
former conditions (Paschen et al., 2003). The blockade of
translation after transient cerebral ischemia may prevent de novo
synthesis of XBP1proc and the downstream effects on gene
expression.
The unfolded proteins accumulated in the ER bind glucoseregulated protein 78 (GRP78), an important sensor of the UPR,
leading to the dissociation of binding partners that act as
transcription factors. These proteins translocate to the nucleus,
where they induce the expression of genes coding for molecular
chaperones and folding enzymes, including GRP78 itself, HERP
(homocysteine-inducible, ER-stress inducible protein), GRP94,
calnexin and PDI (protein disulphide isomerase) (Kokame et al.,
2000; Kokame et al., 2001). An increase in the expression of the
grp94, grp78, herp, calnexin and pdi genes was observed after
transient ischemia using different models (Aoki et al., 2001;
Paschenetal.,2003;Truettneretal.,2009;Urbanetal.,2009),and
this effect was correlated with a small upregulation of GRP78 and
GRP94 protein levels in the hippocampus of rats subjected to the
two-vesselocclusionbrainischemiamodel(Truettneretal.,2009).
A significant upregulation of GRP78 protein levels was also
observed in the ischemic territory after transient MCAO in mice
(Shibata et al., 2003).
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 53
(DEMO PDF Extractor SDK 8.0.0.2542-1528807349)
Takentogether,thestudiesdescribedaboveclearlypointtothe
induction of ER stress indicators in brain ischemia. However,
additional studies are required to determine their relative role in
neuronal death.
1.4. Autophagy in brain ischemia
Macroautophagy (autophagy from hereafter) represents the
degradation of any kind of intracellular components in the
lysosomes, and starts with the formation of a double membrane
vesicle (autophagosome)that sequesterportions of thecytoplasm
that, when fused with the lysosome (autolysosome), allows the
degradation of cargo content by lysosomal proteases (Yang and
Klionsky, 2009). This quality control mechanism is highly active
underphysiologicalconditionsbeingresponsiblefortheregulation
of mitochondrial turnover and clearance of protein aggregates
(Choi et al., 2013). Mice lacking the essential autophagic genes
Atg5 and Atg7 in the central nervous system showed reduced
lifespan, massive neuronal death, formation of inclusion bodies
and accumulation of ubiquitinated proteins (Hara et al., 2006;
Komatsu et al., 2006). However, little is known about how this
pathway is altered after brain ischemia.
An increase in autophagosomes, autolysosomes and LC3-II
protein levels was observed in CA1 neurons after 20min of 2-
vessel occlusion in rats followed by 4–24h of reperfusion,
suggesting activation of autophagy (Liu et al., 2010). However,
whenlysosomeinhibitorswereapplied,LC3-IIproteinlevelsfailed
to elevate indicating an autophagic-flux impairment in the
hippocampus (Liu et al., 2010). An upregulation in LC3-II protein
levels was also observed during reperfusion after 1h of transient
MCAO, but in this case no changes in the autophagic-flux were
observed in the penumbra region (Zhang et al., 2013a). This
discrepancy may be due to the differences in the methodology
used to induce brain ischemia (global vs focal ischemia) and or to
intrinsic properties of the brain region analysed, which was
different in the two sets of experiments. The class III phosphoinositide3-kinase(PI3K)inhibitor3-methyladenine(3-MA),awellknown inhibitor of autophagosome expansion thus inhibiting
autophagy, further increased the infarct volume after transient
MCAO and reinforced apoptotic cell death 24h after OGD in
cultured cerebrocortical neurons (Zhang et al., 2013a). This
increase in vulnerability to OGD in the presence of 3-MA was
due to the defective mitochondrial clearance by the autophagic
pathway thus failing in aborting apoptosis (Adhami et al., 2007;
Zhang et al., 2013a). At this point it is still not understood how
lysosomes are involved in inducing apoptosis under ischemic
conditions. One possible mechanism is through a Bax-dependent
lysosomal-membrane permeabilization with the consequent
cathepsin B and D translocation to the cytosol, thereby triggering
apoptosis (Erdal et al., 2005).
Autophagywasalsoshowntoplayaroleinischemictolerance.
Pheochromocytoma PC12 cells subjected to 6h of ischemic preconditioningshowedadecreasedsurvivalwhenfurtherexposedto
lethal-OGD for 15h in the presence of 3-MA (Park et al., 2009).
Ischemic preconditioning (30min), 24h prior to a lethal exposure
to OGD in the presence of 3-MA abolished the upregulation of
HSP70, HSP60 and GRP78 (protective markers), and upregulated
CHOP,cleavedcaspase-12andcaspase-3(Shengetal.,2012).These
alterations suggest that autophagic induction during ischemic
preconditioningreducestheexcessiveERstresscausedbyharmful
ischemia (Sheng et al., 2012).
2. UPS
The ubiquitin–proteasome system (UPS) is the major intracellular machinery for protein degradation (Ciechanover, 1994). UPS
protein targets are first polyubiquitinated before being degraded
by the proteasome. Under basal conditions, UPS components are
foundinallsubcellularcomponentsincludingthenucleus,plasma
membraneandmitochondria,andareresponsibleformaintaining
cellular homeostasis by regulating several important processes
such as cell division, cell death, signal transduction and
transmembrane transport (Wagner et al., 2011).
2.1. Ubiquitin
Ubiquitinisasmall,heat-stableandhighlyconserved76-amino
acid protein with 8.5kDa, which can be covalently attached to
other proteins (Hershko and Ciechanover, 1998; Fang and Weissman
,2004).Ubiquitinwasfirstdescribedasathymichormoneand
to have lymphocyte-differentiation properties (Goldstein, 1974;
Goldstein et al., 1975; Schlesinger et al., 1975; Hershko and
Ciechanover, 1998), before its role in selective degradation of
proteins was uncovered. Additional studies were required to
identifyasmallprotein,namedAPF-1(ATP-dependentproteolysis
factor 1), which was shown to play an important role in the
selective degradation of APF-1 modified proteins (Ciechanover
etal.,1978,1980).Lateron,giventhesimilaritiesontheaminoacid
sequence and physical properties, it was found that APAF-1 was
indeed ubiquitin (Wilkinson et al., 1980).
Substrate proteins can be modified either by a monoubiquitin,
multiple monoubiquitin (multi-ubiquitination) or by a polyubiquitinchain(polyubiquitination).Forthelatterprocess,anyofthe
seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48,
Lys63)ofubiquitincanbelinkedtothepreviousone,resultingina
sizeable increase of the chains with different configurations
(Grabbe et al., 2011). In an early attempt to quantify the relative
abundance of polyubiquitin chains, using an yeast model, it was
found that K48 polyubiquitin chains are the most abundant ones
(29%),followedbyK11(28%),K63(16%),K6(10.9%),K27(9%),K33
(3.5%) and K29 (3.2%) (Xu et al., 2009b). However, the amount of
proteinsthataresingleubiquitinatedwasnotassessedinthiscase.
A different study also performed in yeast showed that 56% of all
ubiquitin modified proteins are either monoubiquitinated or have
an end-cap ubiquitin, and the remaining bulk is given to
polyubiquitin modified proteins (Ziv et al., 2011). In this case
the relative abundance of different types of polyubiquitin chains
was quite different from the early observations in yeast: the K48
polyubiquitin chains were once again the most prevalent ones
(21%), followed by K63 (18%), K29 (5%), K11 (0.6%), K33 (0.1%)
andK27(0.1%),whileK6wasnotdetected(Zivetal.,2011).These
differencesmayresultfromthedifferentexperimentalapproaches
used in both works.
The myriad of polyubiquitin modifying possibilities is responsible for the high complexity of this system, thus regulating
different outcomes in the modified protein. While K48 polyubiquitin chains target proteins for proteasomal degradation in a
process that requires at least four ubiquitin molecules (Fang and
Weissman, 2004; Ye and Rape, 2009; Lander et al., 2012), noncanonical K63 polyubiquitin chains are associated with nonproteolytic functions (Nathan et al., 2013) such as DNA repair,
kinase activity modulation (Pickart, 2004; Chernorudskiy and
Gainullin, 2013), regulation of plasma membrane protein internalization through the endocytic pathway, and delivery of
internalized proteins for lysosomal degradation (Grabbe et al.,
2011; Wagner et al., 2011). The ubiquitination process is also
important as a protein quality control mechanism. Initial studies
have shown that almost 30% of the newly synthesized proteins
arise as defective ribosomal products, being part of them
ubiquitinated (Schubert et al., 2000). However, the extent of
ubiquitination in the defective ribosomal products and whether
these proteins are ubiquitinated after or during the translation
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 54
(PDF Extractor SDK TRIAL VERSION)
process were not investigated. More recently, two independent
studies further addressed this issue using yeast as a model, but
although similar approaches were used, distinct results were
obtained. One report showed ubiquitination in 12–15% of newly
synthetizedproteinswhiletranslationisoccurring,beingtheeffect
enhanced by misfoldingagentsand HSP70 inhibitors (Wang et al.,
2013). The same authors showed that protein ubiquitination
induced by misfolding agents is prevented by ubiquitin mutants
lacking lysine 48 (Wang et al., 2013). In contrast, the other study
reported that cotranslational ubiquitination occurs at a rate of 1–
5% under basal conditions by a mechanism dependent on the
activity of the Hul5, Hrd1 and Doa10 E3 ligases (Duttler et al.,
2013).
The importance of Lys11-linked polyubiquitin chains in
regulating cell cycle has been recently updated (Wickliffe et al.,
2011), and along with Lys6, Lys27 and Lys29, Lys33-linked
polyubiquitin chains can also direct proteins for proteasomal
degradation (Xu et al., 2009b; Kim et al., 2011; Kulathu and
Komander, 2012). In addition, several studies have shown the
crosstalk between ubiquitination and other post-translational
modifications,includingphosphorylationandacetylation,thereby
increasing the complexity of this signaling network (Beltrao et al.,
2012). Surprisingly, in some cases, mono- and multi-monoubiquitination can also act as proteasomal degradative signals
(Guterman and Glickman, 2004; Boutet et al., 2007; Dimova
et al., 2012; Shabek et al., 2012).
2.2. Ubiquitination machinery
Asapost-translationalmodification,theubiquitinationprocess,
i.e., the process of adding ubiquitin to a substrate protein, and the
removal of these ubiquitin molecules at a later point, is a finely
tuned process governed by a cascade of ubiquitination enzymes
and by deubiquitinating enzymes (DUBs), respectively. Almost 3%
of the human genome is devoted to the ubiquitination machinery
highlighting the importance of this process in cell survival and
homeostasis.
Protein ubiquitination occurs through a sequential action of
three or four different classes of enzymes, E1 or ubiquitin
activating enzyme, E2 or ubiquitin conjugating enzyme and E3
or ubiquitin ligase (Fig. 2). The human genome encodes for 2 E1s,
40E2sand650E3s(YeandRape,2009;deBieandCiechanover,
2011). E1 is the first enzyme involved in the ubiquitination
cascade. It binds to Mg2+-ATP and subsequently to ubiquitin in
order to activate its C-terminal Gly residue (Jin et al., 2007; Finley
et al., 2012). ATP hydrolysis generates an ubiquitin adenylate,
followedbyubiquitintransferencetoaCysresidueofE1througha
thiol-ester linkage, with the release of adenosine monophosphate
(AMP) (Hershko et al., 1983; Jin et al., 2007). Since this activating
step is sequentially repeated, each fully loaded E1 carries two
molecules of ubiquitin, one as a thiol-ester and the other as an
adenylate (Fang and Weissman, 2004; Finley et al., 2012).
Activatedubiquitinisthentransferredtoaconservedcoredomain
of 150 residues (ubiquitin-conjugating (UBC) domain) of an E2
conjugating enzyme that includes an invariant cysteine residue
responsible for accepting ubiquitin from E1 (Fang and Weissman,
2004;YeandRape,2009).Inthethirdstep,ubiquitinistransferred,
specifically, to a substrate protein by an E3 ligase. Two different
classesofE3ligasesareresponsiblefortheinteractionwiththeE2
conjugating enzymes and can serve either as catalytic intermediates
, or mediate the direct transfer of ubiquitin to the substrate.
Homologous to E6-AP Carboxyl Terminus (HECT) E3 ligases serve
as intermediate ubiquitin acceptors through the formation of a
thiol-ester linkage between ubiquitin and the Cys residue in the
HECT domain before ubiquitin is attached to the substrate (Fang
andWeissman,2004;deBieandCiechanover,2011).Ontheother
hand, Really Interesting New Gene (RING) E3 ligases act only as
‘‘scaffold’’ proteins forming an E2-substrate protein complex that
allows the direct transfer of ubiquitin to the target protein (Fang
and Weissman, 2004; Deshaies and Joazeiro, 2009; de Bie and
Ciechanover, 2011). Despite the differences in the mechanisms of
ubiquitin transference to the substrate proteins, both types of E3
ligasesleadtotheformationofanisopeptidebondbetweentheC-
terminal Gly of ubiquitin and a e-NH
2
group of an internal Lys of
the substrate. However, ubiquitin can also be added to other
residues (recently reviewed in de Bie and Ciechanover, 2011).
While the interaction between the E2 and E3 determines the
typeofpolyubiquitinlinkage,anadditionalsubsetofenzymes,E4,
or ubiquitin elongating enzymes, allows the elongation of
ubiquitin chains on those proteins that have been modified
by activated ubiquitin (Koegl et al., 1999; Hoppe, 2005; Finley
et al., 2012).
Fig.2.Maincomponentsoftheubiquitin–proteasomesystem.Inordertobeattachedtothesubstrateprotein,ubiquitinisfirstactivatedbytheE1-activatingenzymeinan
ATP-dependent manner, and further transferred to the E2-conjugating enzyme. The substrate-specificity of this pathway is given by the E3 ligase, which allows the
ubiquitination of a specific substrate. When a proper chain is assembled, with at least four ubiquitin moieties, it is recognized, unfolded and deubiquitinated by the 19S
regulatoryparticle.Thisunfoldingprocessallowstheproteintoenterthe20Scatalyticparticlewhereitisdegradedbytheb
1
(trypsin-likeactivity),b
2
(caspase-likeactivity)
andb
5 (chymotrypsin-like activity) subunits. At the end, small peptides are generated and ubiquitin is regenerated.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 55
(8.0.0.2542,430247260 PDF Extractor SDK TRIAL)
2.3. Deubiquitinating enzymes
The ubiquitination process can be counteracted by deubiquitinating enzymes (DUBs). Five major classes of DUBs have been
described: ubiquitin C-terminal hydrolases (UCHs), ubiquitinspecific proteases (USPs), Machado–Joseph disease protein
domain proteases, ovarian tumor proteases and JAMM motif
proteases (Love et al., 2007). Almost all DUBs are cysteine
proteases, except the JAMM family which are metalloproteases
(Todi and Paulson, 2011). DUBs may be intrinsic to the 26S
proteasome (e.g. Rpn11), or may associate reversibly with the
proteasome(e.g.Uch37andUsp14)(Koulichetal.,2008;Taietal.,
2010;Liuand Jacobson,2013),butmostofthemhavea cytosolic
localization. The overall function of DUBs is to cleave ubiquitinlinked molecules after the C-terminus of the last residue of
ubiquitin (Gly76), being essential to: (i) the maintenance of
monomeric ubiquitin pool, either by cleaving the ubiquitin
precursor or by trimming polyubiquitin chains; (ii) rescue
proteins targeted for degradation, allowing the cell to adapt
quickly to physiological changes, and (iii) prevent ubiquitin–
proteasome dependent protein degradation (Guterman and
Glickman, 2004; Komander et al., 2009). Activation of the DUBs
Usp14andUch37,eitherbypolyubiquitinchainsortheirchemical
mimetics,stimulatesthe19SassociatedATPasestherebyopening
the20Sclosedgate,andthuspromotingpeptidehydrolysis(Peth
et al., 2009, 2013).
2.4. Proteasome
The 26S proteasome is a 2.5MDa multisubunit complex
responsible for controlled ATP-dependent degradation of polyubiquitinatedproteins(Xie,2010).Itiscomposedofacatalytic20S
core particle (CP or 20S proteasome) associated with one (RP
1
CP)
or two (RP
2
CP) 19S regulatory particles (RP or 19S proteasome),
that are responsible for detecting, deubiquitinating and unfolding
ubiquitinated proteins (da Fonseca et al., 2012; Djakovic et al.,
2012). Although RP
1
CP and RP
2
CP can be observed in several cell
types, includingneuronal,kidneyand liver cells,theproportion of
RP
1
CPandRP
2
CPtofree20Sproteasomeisoftenhigherinneurons
(Tai et al., 2010). The highest amount of RP
1
CP is thought to be
better suited for performing a vectorial process which involves
substrate capture and release (Baumeister et al., 1998). The 26S
proteasomeconsistsofatleast66residentsubunitsandassociated
proteins, e.g. E3 ligases and assembling factors, such as molecular
chaperones and others (Leggett et al., 2002; Tai et al., 2010; Xie,
2010).
Once a protein is committed for proteasomal degradation, by
linking at leastfourubiquitinmoietiesand a properpolyubiquitin
chain (Glickman and Ciechanover, 2002; Lander et al., 2012), the
interaction with the 26S proteasome and subsequent deubiquitination allows the translocation to the proteasome followed by
degradation(Fig.2).Attheend,smallpeptidesrangingfrom2to20
amino acids and free ubiquitin are regenerated (Glickman and
Ciechanover,2002).Thecatalyticactivityofthe26Sproteasomeis
significantlyenhanced in thepresence of ubiquitinatedsubstrates
whereas the 20S activity remains unchanged (Peth et al., 2009).
This supports a role for the 26S proteasome in the selective
degradation of ubiquitinated substrates.
The 20S proteasome is a 670kDa barrel-shaped structure
composed of 28 subunits arranged in a four stacked ring
structure: two a
1–7
outer rings and two b
1–7
inner rings (da
Fonseca and Morris, 2008). In the center of the ring, there is a
narrow pore where a protein targeted for degradation can enter
in an unfolded state. In the free CP this pore is closed by the N-
terminus of the a-subunits, namely a
2
, a
3
and a
4
(Xie, 2010).
However, the truncation of thea3 N-terminal is enough to keep
the pore open and increases the degradation of small peptides
(Peth et al., 2009). Besides closing the pore,a-subunits are also
responsible for compartmentalizing the catalytic b-subunits,
thereby preventing uncontrolled cleavage of cytosolic proteins.
Moreover, a proteomic approach revealed that the a
7
subunit
interacts with proteins involved in the processing and splicing
of RNA (Fedorova et al., 2011). The b ring also forms a
central chamber where the peptidylglutamyl-like (cleaving
after acidic residues), trypsin-like (cleaving after basic residues)
and chymotrypsin-like (cleaving after hydrophobic residues)
activities of the 20S proteasome are mediated by the b
1
, b
2
and b
5
subunits, respectively (Fig. 2) (Groll et al., 1997; Beck
et al., 2012).
Theothercomponentofthe26Sproteasome,the19Sregulatory
particle (RP), is a700kDa multisubunit complex composed of at
least 18 subunits. The 19S proteasome serves to recognize,
deubiquitinateand unfoldthe substrateproteins in order to make
them suitable to enter into the 20S catalytic pore. It is divided in
two biochemically distinct sub-complexes: the lid and the base
(Hershko and Ciechanover, 1998; Sakata et al., 2012; Tomko and
Hochstrasser,2013).Thelidconsistsofeightnon-ATPasesubunits,
Rpn3, Rpn5–9, Rpn12 and Rpn11 (a DUB enzyme). The base
contains six distinct AAA+ ATPases, Rpt1–6, and four non-ATPase
subunits, Rpn1, Rpn2, Rpn10 and Rpn13 (Lander et al., 2012;
Tomko and Hochstrasser, 2013). The interaction of polyubiquitinated proteins with the RP base occurs on two intrinsic proteins,
Rpn10 and Rpn13, which are apically located in order to better
captureubiquitinatedsubstrates(Sakataetal.,2012).Rpn10binds
ubiquitinconjugatesthroughitsC-terminusUbiquitin-Interacting
Motif (UIM), and a similar function is mediated by the Rpn13
subunit through a conserved amino-terminal region named
pleckstrin-like receptor for ubiquitin (Pru) domain (Husnjak
et al., 2008; Schreiner et al., 2008; Sakata et al., 2012). The Pru
domain is also important to attach Rpn13 to the proteasome
(Schreiner et al., 2008).
Although recognition of ubiquitinated proteins is, to a certain
extent,consideredtobeastochasticprocess,severalproteinssuch
asRad23andDsk2havebeenshowntoactasshuttlingfactorsand
direct ubiquitinated proteins to the 26S proteasome (Guerrero
etal.,2006).Theseproteinsinteractwithlargescaffoldproteinsof
the base, namely Rpn1 and Rpn2 (Husnjak et al., 2008). Another
shuttling factor, the p62/sequestosome1, associates with the 26S
proteasome through the N-terminal domain (Seibenhener et al.,
2004;MyekuandFigueiredo-Pereira,2011),andparticipateinthe
selective recognition and degradation of ubiquitinated cargo by
selective autophagy (Lamark et al., 2009). While Rpn1 is
responsible for binding shuttling factors such as Rad23 and
Dsk2(Elsasseret al.,2002,2004;Rosenzweigetal.,2012),and the
non-obligatory deubiquitinating enzyme Ubp6/Usp14 (Leggett
et al., 2002; Elsasser et al., 2004; Rosenzweig et al., 2012), Rpn2
only binds the Rpn13 subunit (Schreiner et al., 2008; Rosenzweig
etal.,2012).Thisspecificbindingandthedeliveryofubiquitinated
proteinstotheproteasomebyshuttlingfactorsisdrivenbytheN-
terminal ubiquitin-like domain (UBL), while the C-terminal
ubiquitin associated domain (UBA) is responsible for ubiquitin
binding (Rosenzweig et al., 2012).
The ATPase ring of the 19S proteasome is arranged in a spiral
caseandconstitutesthedrivingforcetounfoldandpullthetarget
proteins to be degraded inside the catalytic core (Lander et al.,
2012).TheRpt2subunitappearstobetheonlyonerequiredforCP
openingandsubstrateentry(Kohleretal.,2001).Twoindependent
studies attributed another function to the base ATPases, in
preventing protein aggregation, by acting as chaperones, and in
mediatingproteinrefoldingandnotunfolding(Braunetal.,1999),
andtheRpt5subunitmayalsobindpolyubiquitinchainsasshown
by crosslinking studies (Lam et al., 2002).
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 56
( 8.0.0.2542.1718146034 PDF Extractor SDK EVALUATION)
2.5. Immunoproteasome
In response to viral, bacterial or other types of stress, the
constitutive catalytic subunitsb
1
,b
2
, andb
5
can be replaced by
threeinduciblesubunits,lowmolecularweightprotein2(LMP2or
b1i),multicatalyticendopeptidasecomplexlike1(MECL1orb2i),
and b5i (LMP7), respectively (Loukissa et al., 2000). The proteasomes containing these subunits are usually referred to as
immunoproteasome (i-proteasome). However, a mixture of the
standardand i-proteasomecatalyticsubunitsmaybefoundatthe
20S catalytic core (Dahlmann et al., 2000), and was shown to
contributetodifferencesincatalyticcoreenzymaticcharacteristics
and cleavage of model substrates (Dahlmann et al., 2000). The iproteasomes play an important role in the immune system,
generating immunogenic peptides for antigen presentation on
MHC class I and recognition by cytotoxic T lymphocytes (Rock
et al., 1994; Goldberg et al., 2002). Although in young healthy
human brain i-proteasomes are almost absent, they have been
detected in brain areas from elderly subjects as well as from
patients affected by Alzheimer (Mishto et al., 2006) and
Huntingtondiseases(Diaz-Hernandezetal.,2003),andinMultiple
Sclerosis (Mishto et al., 2010). Transient focal cerebral ischemia
was also shown to upregulate the protein levels of i-proteasome
subunits LMP2 and LMP7 in the parietal cortex and hippocampus
(Luand Wang, 2012). This upregulationof i-proteasomal subunits
may contribute to recover the proteasomal activity following a
transientcerebralischemicstroke,leadingtoefficientclearanceof
unwanted proteins and thus possibly providing neurons an
increased tolerance to transient ischemia.
3. Role of UPS in nervous system
In yeast cells, the majority of proteasomes have been detected
in the cell nucleus (Russell et al., 1999). However, in mammalian
cells,proteasomesaremainlylocatedatthecytoplasm,withavery
high concentration close to centrosome (Wigley et al., 1999). By
contrast, i-proteasomes are specifically positioned at the endoplasmic reticulum (Brooks et al., 2000). A nuclear localization
signal may also direct proteasomes to the cell nucleus (Tanaka
etal.,1990;Reitsetal.,1997),namelyafterinductionofcellstress
(Ogiso et al., 2002), where they accumulate in focal subdomains
(vonMikecz,2006).Humanplasmaalsocontains20Sproteasomes,
whichwereprobablyreleasedfromdyingcells,andcanpotentially
be used as diagnostic markers (Wada et al., 1993; Lavabre-
Bertrand et al., 2001; Egerer et al., 2002).
Neurons are a very specialized post-mitotic cell type, and
several components of the UPS are present in both pre- and
postsynaptic compartments. In the nervous system, the UPS
regulatesseveralaspectsofsynapticfunction,suchasspinogenesis
(Hamilton et al., 2012), presynaptic neurotransmission (Willeumier et al., 2006; Jiang et al., 2010), long-term potentiation
(Dong et al., 2008; Cajigas et al., 2010; Pavlopoulos et al., 2011),
synaptic scaling (Hou et al., 2011), apical dendrite outgrowth/
polarization(HamiltonandZito,2013;Miaoetal.,2013;Vadhvani
et al., 2013), dendritic arborization (Puram et al., 2013), axon
growth(Yangetal.,2013),andsynapseformationandelimination
(Yi and Ehlers, 2007).
Rat cerebrocortical cell extracts possess a higher proportion of
26Sproteasomes(57%),whencomparedtoHeLacells(39%)and
to rat liver/kidney cell extracts (51%) (Tai et al., 2010). This
differencemaysuggestthatselectiveproteindegradationisamore
prominent and controlled process in the brain when compared to
other organs. In the rodent brain tissue, the mean levels of
unconjugated ubiquitin (122.6pmol/mg) are comparable to the
conjugated form (111.6pmol/mg), and the proportion of polyubiquitinchainsaretoacertainextentsimilartothoseobservedin
yeast cell extracts (K48>K63>K11>K6>K33>K27>K29)
(Na et al., 2012). This points towards the importance of the UPS
in the nervous system, and suggests that selective protein
degradation is a highly controlled process.
Synaptic activity can alter significantly the neuronal proteome
within minutes after postsynaptic receptor activation. In fact,
severalcomponentsoftheUPScanalsoberegulateduponNMDAR
activation (Colledge et al., 2003; Ehlers, 2003). Studies performed
inculturedhippocampalneuronsshowedthatincreasingsynaptic
activityenhancesproteasomeactivityandinducesaredistribution
ofthe26Sproteasomefromdendriticshaftstodendriticspines,as
shown using the degradation reporter UbG76V-GFP and the
proteasome reporter Rpt1-GFP, respectively (Dantuma et al.,
2000; Bingol and Schuman, 2006). These effects were promoted
by Rpt6 phosphorylation on the serine 120 residue by CaMKIIa
(Djakovic et al., 2009; Djakovic et al., 2012), and prevented by
CaMKII inhibition (Djakovic et al., 2009) or by knocking down
CaMKIIa with iRNA (Bingol et al., 2010). Similarly, activation of
NMDAR also stimulates the Ubiquitin C-terminal Hydrolase L1
(UCH-L1), thereby increasing free monomeric ubiquitin levels
(Cartieretal.,2009).Thiscontrastswiththeresultsobtainedusing
light-controlled excitation of individual presynaptic terminals of
hippocampal neurons, which increased polyubiquitin conjugation
but was without effect on the redistribution of free ubiquitin and
proteasomes (Hou et al., 2011). Furthermore, upregulation of
excitatory activity by incubation of hippocampal neurons with
bicucullinefor48hwasshowntoincreaseubiquitinconjugationin
postsynaptic density fractions (Ehlers, 2003).
Postsynaptically,theUPSisresponsibleforregulatingthelevels
and/or localization of several proteins. For example, the NMDAR
subunits, GluN1 and GluN2B, are regulated in an activitydependent manner by the Fbx2 and Mind Bomb-2 (Mib2) E3
ligases,respectively(Katoetal.,2005;Jurdetal.,2008)(Fig.3).The
postsynaptic scaffold proteins PSD-95, Shank and GKAP undergo
selective activity-dependent ubiquitination (Ehlers, 2003), and
while the Murine-double minute 2 (Mdm2) is the putative E3
ligase for PSD-95 (Ehlers, 2003; Tsai et al., 2012), knockdown of
endogenous TRIM3 E3 ligase increases the protein levels of
guanylate kinase-associated protein (GKAP) and Shank (Hung
et al., 2010), suggesting that these two proteins may share a
common E3 ligase (Fig. 3). GKAP phosphorylation by CaMKIIa on
Ser54promotesitsremovalfromsynapticsites,polyubiquitination
andsubsequentdegradationbytheproteasome(Shinetal.,2012).
All these synaptic proteins and others (e.g. bassoon, vesicular
glutamate transporter 1 and 2, vesicle-associated membrane
protein, synapsin) were shown recently to be modified by
ubiquitin, in a proteomic study using an antibody that recognizes
aspecificsignature(K-GGpeptides)generatedaftertrypsinization
of ubiquitin-modified proteins (Na et al., 2012).
TheUPSalsomediatestheinternalizationofseveralmembraneassociated synaptic proteins. The initial studies showed that
AMPA-induced internalization of AMPAR was abolished by the
proteasome inhibitor MG132, but no ubiquitination of AMPAR
subunitswasobservedatthattime(Patricketal.,2003).Additional
studies suggested that this internalization is due to a reduced
stabilization of AMPA receptors into synaptic sites as a result of
PSD-95 degradation (Colledge et al., 2003). More recently, Nedd4
(neuronal-precursor cell-expressed developmentally downregulated gene 4) was identified as the putative E3 ligase for GluA1
(Schwarz et al., 2010), and knockdown of Nedd4 prevented GluA1
C-terminal K868 residue ubiquitination, abolishing AMPAR internalization (Lin et al., 2011) (Fig. 3). The AMPAR GluA2 subunit is
also ubiquitinated in response to bicuculline treatment (Lussier
et al., 2011). Yet, the E3 ligase responsible to ubiquitinate GluA2
subunit differs from the one responsible for GluA1 ubiquitination.
The available evidences suggest that the RNF167 E3 ligase is
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 57
(8.0.0.2542,1158229590 PDF Extractor SDK TRIAL)
involved in GluA2 ubiquitination and, accordingly, knockdown of
this ligase was shown to increase AMPAR mediated currents by
increasing the surface expression of GluA2 and to reduce GluA2
ubiquitination following bicuculline treatment (Lussier et al.,
2012) (Fig. 3). There is still some controversy regarding the
mechanism of AMPAR internalization promoted by synaptic
activity, and in particular the role of ubiquitin-mediated degradation. While some studies showed that internalization and
degradation is blocked by proteasome inhibitors (Hou et al.,
2011;Linetal.,2011),othersrevealedadendriticco-localizationof
the internalized receptors with the lysosomal marker Lamp1A,
suggesting that internalized receptors are delivered to the
lysosomes (Schwarz et al., 2010). Since the internalization of
plasmamembraneproteinsthroughtheendocyticpathwaycanbe
mediated by non-canonical polyubiquitin chains (Groothuis et al.,
2006), the decreased degradation in the presence of proteasome
inhibitorscanstillbeattributedtothelysosomessinceunderthese
conditions there is a decrease in free ubiquitin levels thus
interfering with the ubiquitin-mediated internalization process
(Dantuma et al., 2006).
Dysfunction of the ubiquitination and deubiquitination machineries
, mutations in ubiquitin, proteasomal impairment, and
mutations in proteasome substrates affecting their rate of
degradationunderliethepathogenesisofmanyneurodegenerative
diseases (Dennissen et al., 2012). For instance, the ataxic mouse
(axJ),whichresultsfromamutationintheataxiageneencodingfor
the DUB Usp14, shows deficits in presynaptic neurotransmitter
release and short-term plasticity (Wilson et al., 2002), in addition
to a 35% decrease in free ubiquitinlevels whencompared to wildtypemice(Waltersetal.,2008).Usp14overexpressionrescuedthe
levels of free ubiquitin in the brain, as well as the lifespan and
motor activity of axJ mice to values similar to the wildtype
(Crimmins et al., 2006). Notably, all the negative effects observed
in the axJ phenotype were attributed to the decreased free
ubiquitin levels, resulting ultimately in synaptic dysfunction.
Restoring free ubiquitin levels prevented the early death at 8
weeks of age, body weight loss and presynaptic dysfunction
observed in the ataxic mice (Chen et al., 2011). The deficit in
neurotransmitter release in the axJ mice is in accordance with the
resultsshowingthatinhibitionofUch-L1,anotherDUBabundantly
expressed in neurons, also decreases free ubiquitin levels, thus
increasing the number of synaptic vesicles (Cartier et al., 2009).
Mutations in the RING finger E3 ligase Listerin, observed in the
lister mouse model, also induce biochemical, cellular and
neurological alterations similar to those observed in many
neurodegenerative processes, including deficits in balance and
motor coordination, dystrophic neurites, swollen mitochondria,
reduced number and caliber of motor neurons and hyperphosphorylatedTau(Chuetal.,2009).Thisphenotypesuggestsabroad
effect in the regulation of the proteome. Additional studies, using
Fig.3.Regulationofsynapticproteinsthroughtheubiquitin–proteasomesystem.Thepost-synapticregionisenrichedinseveralproteinsoftheUPS(e.g.ubiquitin,E3ligases,
DUBs).(A)Synapticactivityinducesthetraffickingofthe26Sproteasomefromthedendriticshaftstodendriticspinesthroughassociationwiththeactincytoskeleton.Thisis
promoted by phosphorylation of the 26S proteasome-associated protein Rpt6 on Ser120 by CaMKIIa. In addition, the post-synaptic proteins PSD-95 and GKAP are
ubiquitinated by the Murine-Double Minute 2 (Mdm2) and Trim3 E3 ligases, respectively. The removal of GKAP from the synaptic sites and consequent ubiquitination is
mediatedbyCaMKIIa-dependentphosphorylation onSer54.Shankis alsoubiquitinatedbut theputativeE3ligaseinvolvedremainstobeidentified. (B)Theendocytosis of
AMPAR is also ubiquitin-dependent. Neuronal activity induces the ubiquitination of GluA2 and GluA1 subunits by the RN167 and Nedd4 E3 ligases, respectively.
UbiquitinationoftheGluA1subunitoccursattheC-terminalLys868.TheinternalizationofAMPARcanalsobemodulatedbyregulatingArcproteinlevels,aproteininvolved
intheendolysosomaltransportofAMPAR,bytheE3ligaseUbe3A.AdditionalfunctionshavebeenattributedtoUbe3AsuchasinregulatingGolgiacidification.(C)Different
E3ligasescanalsoactonthesereceptorsdependingontheirsubunitcomposition.TheGluN2BsubunitisubiquitinatedbytheMib2E3ligaseinresponsetoneuronalactivity,
whereas the obligatory GluN1 subunit is ubiquitinated by the Fbx2 E3 ligase. This occurs when the subunit is internalized and at the endoplasmic reticulum level.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 58
(8.0.0.2542.1031651049 PDF Extractor SDK TRIAL VERSIOn)
the budding yeast, showed that, in fact, the Listerin homolog Ltn1
is involved in the mechanism of quality control of proteins,
through association with the ribosomes (Bengtson and Joazeiro,
2010).
The UPS is also responsible of regulating social behavior and
interaction. A role for the UPS in mouse models of Fragile X and
Angelman Syndromes, two well-known forms of autism, was also
unraveledrecently.ThedefectivedegradationofPSD-95,aprocess
required for synapse elimination, by the Mdm2 E3 ligase, may
underlie the excessive dendritic spine number observed in Fragile
Xsyndrome(Tsaietal.,2012).ReducedlevelsoftheUbe3Aprotein
levels, an E3 ligase, has also been associated with the Angelman
Syndrome(Williamsetal.,2010;EbertandGreenberg,2013).This
proteinisupregulatedby synapticactivity therebycontrollingthe
degradation of Arc, a protein involved in AMPAR endocytosis
(Greer et al., 2010). Arc protein is also involved in the mGluR-
dependent long-term depression through AMPAR endocytosis
(Waung et al., 2008), and its nuclear localization regulates
homeostatic plasticity by decreasing GluA1 transcription (Korb
et al., 2013). Knockout mouse models for Ube3A have reduced
hippocampal synaptic GluA1 receptors with a concomitant
decrease in AMPAR mediated current, and reduced levels of
mESPC (Greer et al., 2010). More recently, conditional neuronal
loss of Uba6, an E1 ligase involved in the specific activation of
ubiquitin, was shown to induce hyperactivity, social interaction
deficits, decreased spine density both in the amygdala and in the
CA3 region, and impaired learning and memory in mice (Jin et al.,
2007; Lee et al., 2013). Moreover, a more detailed biochemical
analysis showed that the levels of Ube3A, Shank and Arc were
elevated and decreased, respectively, in this mouse model (Lee
etal.,2013).Thereducedspinedensityisinaccordancewithother
works showing that knockdown of Ube3A in pyramidal neurons
reduces apical dendritic outgrowth (Miao et al., 2013). However,
electrophysiological analysis of the synapses in this mouse model
is still lacking.
4. UPS in ischemic conditions
Despite recent advances, there are still major gaps in the
understanding of pathogenesis of cerebral ischemic injury and
therapeutic options for stroke patients are limited (Moskowitz
et al., 2010). Transient cerebral ischemia is associated with an
inflammatory response and a rapid and excessive production of
various misfolded proteins due to oxidative stress and other
mechanisms (Ge et al., 2007, 2012). Overproduction of damaged
proteins following ischemia is reflected in a pronounced increase
of conjugation of targeted proteins with ubiquitin (Hayashi et al.,
1992).Therefore,theaccumulationofubiquitin-containingprotein
aggregates following ischemia is a general feature. However, the
factors leading to deposition of these aggregates and their
consequences for stroke outcome remain poorly understood.
4.1. UPS and in vivo ischemia models
Transient cerebral ischemia induces irreversible misfolded
proteinaggregateformation.Thefirstreportsshowedthatbriefrat
forebrainischemia,inducedbybilateralcommoncarotidocclusion
combined with a reduction of the mean arterial blood pressure to
50mmHg, evoked a selective and sustained loss of ubiquitin
immunoreactivity in rat hippocampal CA1 neurons (Magnusson
andWieloch,1989).However,afewyearslater,itwasshownthat
the loss of ubiquitin immunoreactivity in gerbil hippocampal CA1
neurons after ischemia induced by bilateral carotid occlusion
(BCO) was a result of free ubiquitin depletion and did not arise
from ubiquitin conjugation (Morimoto et al., 1996). It was also
shown that BCO-induced transient ischemia in gerbils promotes a
transient consumption of free ubiquitin associated with an
increase of conjugated multiubiquitin chains in hippocampal
CA3 and dentate gyrus regions, where neurons survive, but these
changesare persistent in theCA1 region, whereneurons are more
vulnerable and destined to die after 5min of ischemia (Ide et al.,
1999). Under the same experimental conditions, a transient
upregulation of the ubiquitin mRNA was observed in all
hippocampal neurons and in the cerebral cortex, with maximal
effects observed after 6h of reperfusion, which then decreased to
control levels at 48h (Ide et al., 1999). In a two-vessel transient
occlusion model of global ischemia in rats, dying neurons in the
hippocampal CA1 region also exhibited an accumulation of highmolecular weight ubiquitin-conjugated proteins, which were
found in clusters around nuclei and close to the dendritic
membrane during 4–24h reperfusion after 15min ischemia; this
was not observed in CA1 neurons destined to survive or in the
dentate gyrus (Hu et al., 2000). Similar results were obtained at 1,
4, and 24h of reperfusion after 2h MCAO in rats, a model of focal
ischemia (Hu et al., 2001). The ubiquitin-positive immunoclusters
of misfolded/damaged protein aggregates were also found in
postsynapticdensitiesfromhippocampalneuronsofratssubjected
to15minoftwo-vesselocclusionmodelfollowedby4and24hof
reperfusion (Liu et al., 2004). Moreover, selective accumulation of
UBB+1, a mutant ubiquitin that is formed by dinucleotide deletion
in mRNA, causing misreading and production of an aberrant C-
terminus ubiquitin (van Den Hurk et al., 2001), which cannot
ubiquitinate target proteins, was also found in the cytoplasm of
CA1 neurons of gerbils submitted to 5min of bilateral common
carotidarteriesocclusionandreperfusion(Yamashiroetal.,2007).
Thisaccumulationappearedat30minafterischemiainCA1region
and increased up to day 4 after ischemia. The number of neurons
displayingUBB+1accumulationwasalso increasedfrom30minto
6h after ischemia (Yamashiro et al., 2007). These changes were
found to precede neuronal death in the hippocampal CA1 region.
UBB+1 protein was also transiently expressed but did not
accumulate in the surviving neurons of the CA3 region, dentate
gyrus,andfrontalcortex,suggestingthataccumulationofUBB+1is
specifically related to delayed neuronal death of CA1 neurons
(Yamashiro et al., 2007). Since UBB+1 can act as an endogenous
proteasome inhibitor (Lindsten et al., 2002), these observations
furtherpointtoaproteasomaldysfunctioninthehippocampalCA1
region after ischemia and reperfusion. In summary, these results
suggest that ubiquitin-containing clusters of misfolded or damaged proteins are formed in all post-ischemic neurons, primarily
during reperfusion. A recent study suggested that the 15-deoxy-
D12,14-prostaglandinJ2(15d-PHJ
2
)producedbyacyclooxygenasedependentmechanismafterrattransientfocalbrainischemiamay
contribute to the aggregation of ubiquitinated proteins (Liu et al.,
2013). Accordingly, addition of 15d-PHJ
2
to cultures cerebrocortical neurons induced the accumulation and aggregation of
ubiquitinated proteins and downregulated the activity of the
proteasome (Liu et al., 2013).
The clusters of ubiquitinated proteins formed after brain
ischemia may give rise to protein aggregates by an unknown
process,possiblythroughtranslationarrest,buttheaggregatesare
maintainedexclusivelyinCA1neuronsuntiltheirdeath(Huetal.,
2000, 2001; Liu et al., 2004, 2005). In fact, translational complex
components are irreversibly clumped into large abnormal protein
aggregates after transient brain ischemia (Liu et al., 2005) or focal
brain ischemia (Zhang et al., 2006a), suggesting that the
irreversible inhibition of translation in neurons destined to die
afterischemiaiscausedbyirreversibleaggregationoftranslational
complex components, chaperones and protein folding enzymes.
Moreover, proteasomes, particularly the 19S RP, are also sequestered into these protein aggregates in post-ischemic brains (Ge
et al., 2007). Furthermore, cytoplasmic ubiquitin-containing
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 59
(EVALUATION PDF Extractor SDK 8.0.0.2542.2087665540)
aggregates and stress granules are clustered together in CA1
neurons at day 2–3 of reperfusion following global forebrain
ischemia and may contribute to sustained translation arrest and
CA1 pyramidal neuron vulnerability (DeGracia et al., 2007).
Recent work also demonstrates that reperfusion rather than
ischemia leads to the accumulation of ubiquitin aggregates in the
neocortex, an area of more intense reperfusion, as well as in the
striatum after transient focal ischemia (MCAO) (Hochrainer et al.,
2012).However,noubiquitinaggregateswerefoundinpermanent
ischemia and surprisingly proteasome impairment was greatest
under these conditions (Hochrainer et al., 2012), suggesting that
the two events are independent. Alternatively, the absence of
ubiquitinaggregatesunderthelatterconditionsmaybeattributed
toATPdepletion,whichshouldpreventtheactivationofubiquitin
by the ATP-dependent E1 ligase, thereby reducing protein
ubiquitination (Huang et al., 2013). Taken together, the available
evidence suggests that the formation of ubiquitin–protein
aggregates may reflect a greater potential for tissue survival in
the immediate postischemic period (Fig. 4). The cause and effect
relationship between protein aggregation and subsequent neuronal death still remains to be determined and further studies are
needed to uncover the roles of ubiquitinated protein aggregation
after brain ischemia.
Accumulationofubiquitinconjugatedproteinsanddepletionof
free ubiquitin followingan ischemic injury suggest impairmentof
proteasome function. In fact, transient global brain ischemia
impairs 26S proteasome function by promoting proteasome
disassembly, both in rats (Ge et al., 2007) and gerbils (Kamikubo
and Hayashi, 1996; Asai et al., 2002). However, while the 26S
proteasome activity recovers in many regions after reperfusion
(e.g. CA3, dentate gyrus, and frontal cortex), in more vulnerable
areas, such as CA1 region of the hippocampus, the 19S and 20S
proteasomes do not fully reassociate, and the proteasome is
irreversibly inhibited (Asai et al., 2002). A time-dependent
decrease in proteasome activity has also been detected in
ipsilateral cortex and hippocampus during 1–24h reperfusion
after transient focal ischemia (Keller et al., 2000), and this
downregulation of proteasome activity was partly attributed to
oxidative stress (Keller et al., 2000). Furthermore, it was shown
thatproteasomesaredisassembledafteranepisodeofglobalbrain
ischemia, partially because of ATP depletion (Fig. 4) (Asai et al.,
2002). It remains to be determined why the ATP-dependent
reassembly of 26S proteasome is selectively impaired in the
hippocampal CA1 region.
Transient forebrain ischemia induced by bilateral common
artery occlusion in Mongolian gerbils and transient focal brain
ischemia induced by MCAO in mice were without effect on the
expression of proteasome subunits, although a downregulation of
the proteasome activity was found in both cases (Kamikubo and
Hayashi, 1996; Keller et al., 2000). These evidences suggest that
posttranslationalmechanismsareinvolvedinthedownregulation
of the proteasome in the ischemic brain. Transient focal cerebral
Fig.4.OverviewoftheconsequencesofbrainischemiaontheUPS.TransientischemiadecreasestheATPcontentoftheaffectedareas,whichcontributesto26Sproteasome
disassembly, leading to accumulation of ubiquitinated proteins and/or failure of the ubiquitin activating enzyme (E1), thus decreasing the overall efficiency of protein
degradationbytheUPS.Afterreperfusionoftheinjuredarea,26Sproteasomesarerequestedtodegradetheaccumulatedubiquitinconjugatesandbecomesequestered.Since
thereisalargeamountof26Stargetedproteins,proteasomealsobecomeblocked.Theaccumulationofnewmisfoldedproteinswillleadtotheformationofaggregates.ATP
decrease after ischemic injury may also contribute to the failure of quality-control mechanisms, which also contribute to aggregate formation. Aggregate formation is a
protective response of the cell against abnormal proteins.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 60
(BY PDF Extractor SDK TRIAL VERSION)
ischemia in mice was also shown to upregulate the expression of
immunoproteasomal subunits (LMP2 and LMP7), both in the
nuclear and cytosolic compartments. These alterations were
mainlyobservedinneuronsandconsideringthatthei-proteasome
displays an increased proteolytic activity (van Deventer and
Neefjes,2010)itmaycontributetotherecoveryoftheproteasome
activity following the ischemic insult. This delayed response may
increasetolerancetotransientischemiabyallowingtheclearance
of unwanted proteins.
Insummary,brainischemiainducesanexcessiveaccumulation
of ubiquitinated proteins, which are in excess to be degraded by
the proteasome (Fig. 4). The accumulation of ubiquitinated
proteins is further increased due to the impairment of the
proteasome activity, giving rise to aggregates that also contain
other unfolded/damaged proteins or organelles, as observed in
delayed neuronal death after brain ischemia.
4.2. Changes in the UPS in in vitro models of global ischemia
OGD,aninvitromodelfortransientglobalischemia,wasshown
to induce hippocampal neuronal death, through activation of
NMDA receptors, and to downregulate proteasome activity in a
NMDA receptor activation-dependent manner (Caldeira et al.,
2013). This OGD-induced decline on proteasome activity may be
duetoarapidATPdepletion.AdecreaseinATPcontentwasinfact
observed in cultured cortical neurons subjected to OGD followed
by reoxygenation (Chen et al., 2010) and in cultured hippocampal
neurons subjected to excitotoxic stimulation (see Section 4.3)
(Caldeira et al., 2013). However, irreversible ATP-independent
inhibition of proteasome activity was detected in hippocampal
CA1 neurons after transient forebrain ischemia (Asai et al., 2002),
suggesting that two different mechanisms may be involved in the
regulation of proteasome activity after OGD.
OGDfollowedbyincubationincultureconditionedmedium(to
mimic reperfusion) induces protein oxidative damage in cultured
cortical neurons. The upregulation in oxidized proteins is coupled
to an increase in protein degradation, both during and after OGD
(Weih et al., 2001). Inhibition of the proteasome was shown to
prevent proteolysis of oxidized proteins after OGD, suggesting a
role for the UPS in the clearance of oxidized proteins in neuronal
cells. Moreover, proteasomal activity was found to be similar
immediately after OGD and in sham-washed cultured cortical
neurons (Weih et al., 2001), in agreement with the relative
resistance of the proteasome against oxidative stress (Reinheckel
et al., 1998). However, these results contrast with the protein
aggregation and reduced cytosolic and nuclear free ubiquitin
distributionreportedintheorganotypichippocampalsliceculture
model of OGD (Ouyang et al., 2005). OGD followed by reoxygenation induced a time-dependent ubiquitination of misfolded
proteins and aggregate formation, specially clustered near nuclei
ofculturedcorticalneurons(Chenetal.,2010).Theseeffectsseem
to be mediated by a dysregulation of endoplasmic reticulum Ca2+
concentration, which affects protein folding. Interestingly, endoplasmic reticulum Ca2+ dysregulation also partially affects
proteasome activity after OGD (Chen et al., 2010). These findings
point to the UPS as an active component of the cellular defense
system against oxidative stress after cerebral ischemia.
4.3. UPS in glutamate-induced excitotoxicity
Activation of NMDA receptors plays a role in neuronal death
induced by transient OGD in different neuronal culture systems
(Martinez-Sanchez et al., 2004; Bonde et al., 2005; Ahlgren et al.,
2011; Caldeira et al., 2013), similarly to the role of glutamate
receptors in neuronal damage in the ischemic brain [for review
(Kostandy, 2012)]. The activation of NMDA-type glutamate
receptors is likely to be a mediator in OGD and ischemia-induced
downregulation of the proteasome activity, as shown in experiments where cultured hippocampal neurons were subjected to
excitotoxic stimulation with glutamate or with NMDA (Caldeira
et al., 2013). The downregulation of the proteasome activity after
excitotoxicstimulationwithglutamateisspecificallymediatedby
activationofextrasynapticNMDAreceptors(Caldeiraetal.,2013),
in agreement with their role in excitotoxic neuronal death
(Bengtson et al., 2008). In particular, the entry of calcium through
NMDARchannelsisactivelyinvolvedinthedownregulationofthe
proteasome activity, possibly due to activation of downstream
signaling pathways that target proteasome proteolytic activity.
The effects of excitotoxic stimulation with glutamate on the
activity of the proteasome, as measured with fluorogenic
substrates after native gel electrophoresis, correlate with a
disassembly of the 26S proteasome, by a mechanism that may
be related with the decrease in the ATP content (Caldeira et al.,
2013). These structural changes in the proteasome resemble the
alterationsintheproteasomestructureobservedinbrainischemia
(Kamikubo and Hayashi, 1996; Asai et al., 2002; Ge et al., 2007),
furthersuggestingthatoveractivationofglutamatereceptorsplays
akeyroleinthedownregulationoftheproteasomeintheischemic
brain.
Although it is still unknown which are the signaling cascades
that mediate the downregulation of the proteasome activity in
brainischemia,theactivationofcalpainsandlysosomalcathepsins
are good candidates, given the fact that the toxic effects of
glutamatearepartiallymediatedbytheCa2+-dependentactivation
ofcalpains(Takanoetal.,2005)andbothproteaseswereshownto
be activated before downregulation of the proteasome in
hippocampal neurons subjected to excitotoxic stimulation (Melo
et al., 2013). Accordingly, a recent study showed a calpainmediated cleavage of the Rpn10 protein in cultured cortical
neurons with compromised ATP production, and the cleavage of
this subunit may affect the assembly of the 26S proteasome
(Huangetal.,2013).Thelysosomalcysteineproteases,cathepsin-B
and cathepsin-L are also involved in ischemic cerebral damage
(Seyfried et al., 2001) and in proteasomal subunit degradation
(Cuervoetal.,1995).Thisisinagreementwiththeresultsshowing
that the excitotoxicity-induced proteasome inhibition is partially
preventedbyinhibitionofcathepsin-L(Caldeiraetal.,2013).Taken
together, these results suggest a cross-talk between different
familiesofproteasesandtheproteasomewhichislikelytoregulate
the cell fate (Sun et al., 2004; Stoehr et al., 2013).
The studies on the effect of excitotoxic stimulation on the
activity of the proteasome showed a preferential targeting of
nuclear proteasomes in cultured hippocampal neurons (Caldeira
et al., 2013), but the differential effects when compared with the
cytoplasmicpopulationofproteasomesarestillnotunderstood.In
additiontothechangesintheactivityoftheproteasome,excessive
NMDARstimulationinculturedcorticalneuronswasalsoshownto
induce hyperphosphorylation of the Anaphase-Promoting complex
/cyclosome (APC/C) Cdh1 activator protein, which leads to a
cytosolicaccumulationofthisE3ligaseresponsibleforthecontrol
of cell cycle progression (Peters, 2002; Maestre et al., 2008). The
effectofexcitotoxicstimulationismediatedbycalpaincleavageof
cyclin-dependentkinase-5(Cdk5),withformationofap25product
that induces the hyperphosphorylation of Cdh1 (Maestre et al.,
2008). In this case, the downregulation of the E3 ligase in the
nucleusallowstheaccumulationofcyclinB1inthiscompartment,
thus inducing apoptotic cell death by abnormal entry in S-phase
(Almeidaetal.,2005;Maestreetal.,2008).Excitotoxicstimulation
with glutamate also downregulated total DUB activity in cultured
hippocampal neurons although no effect was observed on the
activity of Uch-L1, showing that not all deubiquitinating enzymes
are affected (Caldeira et al., 2013). Together, these results suggest
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 61
(DEMO PDF Extractor SDK 8.0.0.2542-31305769)
that the UPS is subjected to regulation at different levels in brain
ischemia, and differential effects may be expected in distinct
subcellular compartments.
Given the evidences pointing to a role of the UPS in the
regulation of glutamatergic synapses (see Section 3.2), the
downregulation of the proteasome observed in brain ischemia
may have important implications at this level. A neurotoxic insult
with glutamate (100mM during 4h) was shown to decrease the
number of PDS-95 puncta and to cause PSD loss, which was
accompanied by spine loss in cultured hippocampal neurons
(Waataja et al., 2008). These effects were attenuated by NMDA
receptor antagonists, but protective effects were also observed in
the presence of a proteasome inhibitor and by a genetic approach
expressing p14ARF (which binds and inhibits mdm2, an E3 ligase
known to ubiquitinate PSD-95, targeting the protein for proteasomal degradation). This study suggests that glutamate activates
NMDAreceptorstostimulateaCa2+-dependentE3ligaseleadingto
PSD-95 ubiquitination and degradation by the proteasome, with
consequent loss of PSD-95 clustering (Waatajaet al., 2008). Taken
together, these evidences suggest that some of the alterations
resulting from proteasome inhibition in brain ischemia may
actually be protective. Accordingly, proteasome and calpain
inhibition did protect the neuronal markers for dendrites (MAP-
2), axons (Neurofilament-H) and the vesicular glutamate transporters(VGLUT1-2)inculturedhippocampalneuronssubjectedto
excitotoxic stimulation (Melo et al., 2013).
Brain ischemia also has a strong impact in GABAergic
neurotransmission, and in particular the downregulation in the
postsynaptic expressionof GABA
A
receptors largelycontributes to
a decrease in inhibitory activity. Excitotoxic stimulation with
glutamate was shown to induce UPS-dependent cleavage of
glutamic acid decarboxylase (GAD; GAD65/67), the enzyme
involved in the synthesis of GABA, in cultured hippocampal
neurons (Baptista et al., 2010). GAD cleavage decreased enzyme
activity and changed the subcellular distribution of GAD65
(Baptista et al., 2010). These alterations are expected to decrease
GABA production and to downregulate GABAergic synaptic
transmission, thereby contributing to neuronal death.
Taken together, the available evidences show that excitotoxic
stimulation with glutamate has multiple effects on the ubiquitin–
proteasomesystemwhichmaycontributetothedemiseprocessin
brain ischemia and in other neurological disorders.
4.4. UPS in ischemic tolerance
Ischemic tolerance is a neuroprotective mechanism in brain,
whereby prior exposure to a brief non-toxic ischemic event
induces protection to subsequent normal harmful ischemic insult
(for review see Meller, 2009). Two mechanisms of ischemic
tolerance have been described: (i) classical or delayed ischemic
tolerance, which requires protein synthesis and changes in the
genomic response, resulting in protection after 24–72h after the
preconditioning stimulus (Barone et al., 1998), and (ii) rapid
ischemic tolerance, independent of new protein synthesis and
producing neuroprotection within 30min to 1h following the
preconditioning event (Meller et al., 2006), suggesting a role for
posttranslational mechanisms (for review Meller, 2009).
UPS has been shown to play an important role in both types of
ischemictolerance.Infact,afterdelayedischemictolerance(5min
ofbilateralcommoncarotidarteryocclusionat48hofreperfusion
after a preconditioning stimulus of 2min) the abundance of free
ubiquitin was found to be restored above the normal values, in
contrast with the ischemia-induced moderate and transient
reduction of free ubiquitin. Although the results suggest de novo
ubiquitin synthesis, no changes were observed in the ubiquitin
mRNA(Ideetal.,1999).AroleofUPSonrapidtolerancetoischemia
was also described. A proteomic analysis (using ubiquitin pulldown assay and mass spectrometry) of ubiquitinated proteins
showed an upregulationof 17 proteins incultured cerebrocortical
neuronsafterapreconditioningischemiceventinvitro(OGD-pretreated cells) and 7 proteins were exclusive of control samples.
Moreover,itwasshownthatacelldeath-associatedprotein,Bcl-2-
interacting mediator of cell death (Bim), is selectively ubiquitinatedanddegradedbytheproteasomeinculturedcorticalneurons
preconditioned with 30min of OGD and 1h of recovery followed
by 120min of OGD and 24h of post-incubation in culture
conditioned medium (Meller et al., 2006). These results suggest
a rapid degradation of cell death promoting proteins and rapid
neuroprotection by the UPS. Moreover, the UPS was found to
increase neuronal resistance to excitotoxicity through rapid
modulation of postsynaptic densities after preconditioning ischemia (Meller et al., 2008). Ubiquitination and degradation of
proteins involved in the structure and function of PSD, namely
MARCKS (myristoylated, alanine-rich C-kinase substrate) and
fascin (actin binding proteins), result in the reorganization of
actin cytoskeleton after preconditioning ischemia. These alterationsresult intheloss ofNMDARfromthePSDanda concomitant
selective attenuation of toxic NMDAR-mediated signaling at the
time when tolerance to ischemia is acquired (Meller et al., 2008).
Accordingly, inhibition of proteasome activity was found to block
the rapid ischemic tolerance-induced neuroprotection (Meller
etal.,2008).Accordingly,activationofNMDAreceptorswasshown
to induce PSD-95 degradation by the UPS, together with a loss of
dendritic spines, in cultured cerebrocortical neurons (Waataja
et al., 2008). The neuroprotective effects (cerebral infarct size,
memory and motor performance) induced by both acute and
delayed ischemia preconditioning are also attenuated when the
proteasome is inhibited with Z-Leu-Leu-Phe-CHO (Rehni et al.,
2010), further suggesting that immediate as well as prolonged
beneficial effects of ischemic preconditioning in global cerebral
ischemia and reperfusion (17min BCAO followed by 24h
reperfusion) may be attributed to UPS activity.
A recent report showed that ischemic postconditioning (three
cyclesof30sreperfusionand30sreocclusionafter2hofMCAOin
rat) can be neuroprotective, since it decreases the size of cerebral
infarction and increases the activities of superoxide dismutase,
catalaseandproteasome,therebydecreasingthelevelsofoxidized
proteins and downregulating the formation of cytotoxic protein
aggregates (Li et al., 2012). Moreover, ischemic postconditioning
was also found to have a protective effect on hippocampal CA1
neurons (Liang et al.,2012). Inthis study,ischemicpostconditioning (15min of two vessel occlusion transient global ischemia
followed by three cycles of 30s reperfusion and 30s clamping in
rat) prevented neuronal death in the hippocampal CA1 region
caused by transient ischemia and reperfusion (Liang et al., 2012).
Thiseffectwasaccompaniedbyadecreaseinubiquitincontaining
aggregates and partial inhibition of the effects of ischemia/
reperfusion on the proteasome activity and abundance (Liang
et al., 2012), suggesting that ischemic postconditioning rescued
neuronaldeathinthehippocampalCA1regionbysuppressingthe
formation of protein aggregates.
4.5. Protective effects of proteasome modulators in brain ischemia
The experimental evidence described in Sections 4.1 and 4.2
pointtoadownregulationoftheUPSinbrainischemia,asobserved
for example by an increase in the accumulation of ubiquitinated
proteins, which correlates with neuronal death. Furthermore,
injectionofaproteasomeinhibitorintothelateralventricleofrats
significantly decreased NF-kB activity and resulted in apoptotic
neuronal death in various CNS areas, suggesting that proteasome
inhibition induces apoptotic neuronal death (Taglialatela et al.,
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 62
(EVAL PDF Extractor SDK 8.0.0.2542-974923585)
1998). Also, incubation of different types of neurons with
proteasome inhibitors was shown to induce cell death (Keller
and Markesbery, 2000; Qiu et al., 2000; Bobba et al., 2002; Ding
et al., 2006). These results would further suggest that proteasome
inhibition contributes to neuronal death in brain ischemia.
However, in contrast with the evidence described above, proteasomeinhibitorswereshowntoprovideneuroprotectioninvarious
models of stroke.
CVT-634, the first proteasome inhibitor to be tested in a rat
modeloffocalbrainischemia,reducedinfarctionwithoutaffecting
regionalcerebralbloodflow(Buchanetal.,2000).Amoredetailed
characterization of the neuroprotective properties of proteasome
inhibitors in brain ischemia was provided with studies using
MLN519 (previously named PS519), a compound structurally
similartolactacystin(Williamsetal.,2003).TheeffectofMLN519
was tested using transient MCAO (Phillips et al., 2000; Williams
et al., 2003, 2004, 2005) and the cardioembolic stroke model
(Zhang et al., 2001), and a therapeutic window of 6–10h after
ischemia/reperfusion brain injury was observed using the former
model.TheneuroprotectiveeffectsofMLN519wereattributedtoa
decrease in inflammation after the ischemic injury, through
downregulation of NF-kB and downstream inflammatory genes,
as well as inhibition of the infiltration of inflammatory cells into
thebrain.Theeffectsoftheproteasomeinhibitorwereobservedon
the‘early’and‘delayed’inflammatoryresponsesaftertheischemic
injury, characterized by neutrophil infiltration and macrophage
invasion, respectively, even with delayed treatments (Phillips
et al., 2000; Zhang et al., 2001; Berti et al., 2003; Williams et al.,
2003,2004).Adetailedimmunohistochemicalanalysisofthecells
showing an increase in NF-kB immunoreactivity after transient
MCAO, showed the highest levels in leukocytes and endothelial
cells,butthiseffectwassignificantlyreduceduponadministration
of MLN519 (Williams et al., 2003). Furthermore, intravenous
administration of MLN519 significantly downregulated cell adhesionmolecules,particularlyinendothelialcells(Bertietal.,2003).
Considering the cell specific effects of MLN519 and its relatively
poor penetration across the blood–brain barrier (BBB), it was
suggested that the effects of proteasome inhibition in brain
ischemia may be mediated primarily at the BBB to interfere with
thepenetrationofinflammatorycells(Phillipsetal.,2000).Infact,
proteasome inhibitors may also act directly on leucocytes to
prevent their entry into the brain (Williams et al., 2004).
In addition to the effects in reducing the brain pathology,
MLN519 also improved the neurological outcome after MCAO
(Phillipsetal.,2000;Zhangetal.,2001;Williamsetal.,2003,2005).
Furthermore, when combined with tissue plasminogen activator
(tPA), MLN519 reduced the infarct volume and improved the
neurological outcome as determined 1 week after stroke (Zhang
et al., 2001). Similarly, the proteasome inhibitor bortezomib
combined with low doses of tPA showed additional neuroprotectiveeffectswhentestedinamodelofembolicstrokeinrats(Zhang
etal.,2006b,2010).Singleadministrationofbortezomibwithin2–
4h after injury also showed neuroprotective effects, and the
proteasome inhibitor was proposed to act by promoting eNOS-
dependent vascular protection and to prevent NF-kB-dependent
vascular disruption (Zhang et al., 2006b,c, 2010).
Althoughbortezomibhasbeenapproved bytheFoodand Drug
Administrationforthetreatmentofmultiplemyelomaandmantle
cell lymphoma, the clinical use of this proteasome inhibitor is
limitedbecauseofseveresideeffects(Ruschaketal.,2011).Anovel
proteasome inhibitor, BSc2118, which is putatively better tolerated
, was shown to provide protection in mice subjected to
intraluminal MCAO, when injected intrastriatally no later than
12hpost-stroke.AsingleinjectionofBSc2118providedlong-term
neuroprotection, reduced functional impairment, stabilized the
blood–brain barrier by decreasing MMP9 activity and enhanced
angioneurogenesis. The upregulation of the HIF1A transcription
factor is also an important mediator in BSc2118-induced
neuroprotection (Doeppner et al., 2012). Furthermore, BSc2118
treatment increased the levels of erythropoietin, brain-derived
neurotrophic factor and vascular endothelial growth factor,
suggesting that the proteasome inhibitor may provide acute
neuroprotection in addition to enhancing brain remodeling
(Doeppner et al., 2012).
The apparent contradiction between the neuronal death
resultingfromproteasomeinhibitionandtheeffectofproteasome
inhibitors in brain ischemia may be explained by an effect of
proteasomeinhibitioninthesecondaryphaseofbraininjuryandin
neuroinflammation after stroke, which are reduced by these
compounds. Although neurons are sensitive to proteasome
inhibition, they may be able to tolerate relatively long periods
of intracellular accumulation of ubiquitinated proteins, allowing
the control of neuroinflammation with the proteasome inhibitors.
The recent development of small molecule inhibitors of
deubiquitinating enzymes (USP and other classes of DUBs), which
stabilize the polyubiquitin chains bound to their specific targets
and thereby promote their degradation, will allow testing the
effect of upregulating the proteasome activity on ischemiainduced neuronal damage. From the experimental and clinical
points of view, these molecules will benefit from the specificity of
each one of the USP. A recent study reported the effect of IU1,
which acts as a Usp14 inhibitor, a DUB that acts as a negative
regulatorofthe26Sproteasome(Leeetal.,2010),ontransientfocal
cerebral ischemia induced by MCAO. Administration of IU1 1 day
before MCAO significantly reduced the infarct volume, when
determined 4 days after the lesion. In this case the effects of IU1
were correlated with the control of REST protein levels, which is
known to increase in ischemic neurons destined to die (Doeppner
etal.,2013).However,itremainstobedeterminedwhetherIU1is
alsoneuroprotectivewhenadministeredaftertheischemicinjury.
The upregulation of protein degradation by the proteasome in the
presence of IU1 may compensate for the toxic effects resulting
from a downregulation of the proteasome activity in brain
ischemia. However, additional studies should be performed to
investigate the cellular and molecular mechanisms of neuroprotection by this DUB inhibitor.
5. Conclusions
The available evidence clearly point to a role of excitotoxic
damage in ischemia-induced downregulation of the proteasome
activity,whichmaycontributetoneuronaldeath.However,atthis
point we have a limited understanding of the effect of brain
ischemiaontheothercomponentsoftheUPS,inparticularligases
and deubiquitinases, which should have an impact on the
abundance of their target proteins. The results showing distinct
effectsofexcitotoxiccelldamageontheactivityoftheproteasome
in the nuclear and cytosolic compartments also suggest that UPS
targetsmaybe differentiallyaffected in brain ischemiadepending
on their location in the cell. In particular, alterations in the UPS in
the nuclear compartment may affect the activity of transcription
factors,therebyalteringgeneexpression.GiventheroleoftheUPS
in synaptic regulation, alterations in the proteasome activity may
also lead to changes in the activity of excitatory and inhibitory
synapses. Although proteasome inhibitors have been shown to
provide protection in brain ischemia, alternative strategies,
specifically targeting the molecular mechanisms responsible for
neuroinflammation, are likely to provide better results since
they would avoid exacerbating the problems arising from the
stroke-induced downregulation of the proteasome. The future
development of small molecule inhibitors of deubiquitinating
ubiquitin-specific proteases (USP) (Zhang et al., 2013b) and other
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 63
(PDF Extractor SDK TRIAL VERSION)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0005
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0005
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0010
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0010
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0020
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0020
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0030
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0030
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0030
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0035
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0035
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0035
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0040
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0040
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0040
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0055
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0055
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0065
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0065
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0075
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0075
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0080
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0080
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0080
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0085
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0085
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0090
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0090
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0105
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0105
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0105
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0105
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0115
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0115
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0120
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0120
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0130
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0130
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0140
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0140
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0145
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0145
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0145
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0150
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0150
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0155
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0155
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0160
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0160
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0175
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0175
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0180
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0180
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0185
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0185
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0195
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0195
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0205
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0205
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0205
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0210
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0210
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0215
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0215
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0225
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0225
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0230
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0230
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0235
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0235
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0235
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0255
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0255
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0255
deubiquitinating enzymes (Tan et al., 2008) will also allow
modifying in a more specific manner the abundance of protein
targets of the UPS and may prove to be useful as neuroprotective
strategies in brain ischemia. Furthermore, although proteasome
inhibitors and activators have shown neuroprotective effects in
cerebral ischemia the detailed biochemical alterations in the
ubiquitin-modified landscape after ischemia remain to be elucidated.
Acknowledgements
TheworkintheauthorslaboratoryisfundedbyFundac ¸a ˜oparaa
Cie ˆnciaeTecnologia,COMPETE(ProgramaOperacionalFactoresde
Competitividade), QREN and FEDER (Fundo Europeu de Desenvolvimento Regional) (PTDC/SAU-NMC/120144/2010, PTDC/NEUNMC
/0198/2012 and PEst-C/SAU/LA0001/2011).
References
Aarts,M.,Iihara,K.,Wei,W.L.,Xiong,Z.G.,Arundine,M.,Cerwinski,W.,MacDonald,
J.F., Tymianski, M., 2003. A key role for TRPM7 channels in anoxic neuronal
death. Cell 115, 863–877.
Adhami, F., Schloemer, A., Kuan, C.Y., 2007. The roles of autophagy in cerebral
ischemia. Autophagy 3, 42–44.
Ahlgren, H., Henjum, K., Ottersen, O.P., Runden-Pran, E., 2011. Validation of organotypical hippocampal slice cultures as an ex vivo model of brain ischemia:
different roles of NMDA receptors in cell death signalling after exposure to
NMDA or oxygen and glucose deprivation. Cell Tissue Res. 345, 329–341.
Almeida, A., Bolanos, J.P., Moreno, S., 2005. Cdh1/Hct1-APC is essential for the
survival of postmitotic neurons. J. Neurosci. 25, 8115–8121.
Aoki,M.,Tamatani,M.,Taniguchi,M.,Yamaguchi,A.,Bando,Y.,Kasai,K.,Miyoshi,Y.,
Nakamura, Y., Vitek, M.P., Tohyama, M., Tanaka, H., Sugimoto, H., 2001. Hypothermictreatmentrestoresglucoseregulatedprotein78(GRP78)expressionin
ischemic brain. Brain Res. Mol. Brain Res. 95, 117–128.
Araujo, I.M., Verdasca, M.J., Leal, E.C., Bahr, B.A., Ambrosio, A.F., Carvalho, A.P.,
Carvalho, C.M., 2004. Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal
neurons. J. Neurochem. 91, 1322–1331.
Asai,A.,Tanahashi,N.,Qiu,J.H.,Saito,N.,Chi,S.,Kawahara,N.,Tanaka,K.,Kirino,T.,
2002. Selective proteasomal dysfunction in the hippocampal CA1 region
after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 22,
705–710.
Bano,D.,Young,K.W.,Guerin,C.J.,Lefeuvre,R.,Rothwell,N.J.,Naldini,L.,Rizzuto,R.,
Carafoli, E., Nicotera, P., 2005. Cleavage of the plasma membrane Na+/Ca2+
exchanger in excitotoxicity. Cell 120, 275–285.
Baptista, M.S., Melo, C.V., Armelao, M., Herrmann, D., Pimentel, D.O., Leal, G.,
Caldeira, M.V., Bahr, B.A., Bengtson, M., Almeida, R.D., Duarte, C.B., 2010. Role
of the proteasome in excitotoxicity-induced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons. PLoS One 5, e10139.
Barone, F.C., White, R.F., Spera, P.A., Ellison, J., Currie, R.W., Wang, X., Feuerstein,
G.Z.,1998.Ischemicpreconditioningandbraintolerance:temporalhistological
and functional outcomes, protein synthesis requirement, and interleukin-1
receptor antagonist and early gene expression. Stroke 29, 1937–1950.
Baumeister,W.,Walz,J.,Zuhl,F.,Seemuller,E.,1998.Theproteasome:paradigmofa
self-compartmentalizing protease. Cell 92, 367–380.
Beck, P., Dubiella, C., Groll, M., 2012. Covalent and non-covalent reversible proteasome inhibition. Biol. Chem. 393, 1101–1120.
Beltrao, P., Albanese, V., Kenner, L.R., Swaney, D.L., Burlingame, A., Villen, J., Lim,
W.A., Fraser, J.S., Frydman, J., Krogan, N.J., 2012. Systematic functional prioritization of protein posttranslational modifications. Cell 150, 413–425.
Bengtson, C.P., Dick, O., Bading, H., 2008. A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity
against neurotoxicity. BMC Neurosci. 9, 11.
Bengtson, M.H., Joazeiro, C.A., 2010. Role of a ribosome-associated E3 ubiquitin
ligase in protein quality control. Nature 467, 470–473.
Berti,R.,Williams,A.J.,Velarde,L.C.,Moffett,J.R.,Elliott,P.J.,Adams,J.,Yao,C.,Dave,
J.R., Tortella, F.C., 2003. Effect of the proteasome inhibitor MLN519 on the
expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. Neurotoxicol. Res. 5, 505–514.
Bevers, M.B., Neumar, R.W., 2008. Mechanistic role of calpains in postischemic
neurodegeneration. J. Cereb. Blood Flow Metab. 28, 655–673.
Bingol,B.,Schuman,E.M.,2006.Activity-dependentdynamicsandsequestrationof
proteasomes in dendritic spines. Nature 441, 1144–1148.
Bingol, B., Wang, C.F., Arnott, D., Cheng, D., Peng, J., Sheng, M., 2010. Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic
spines. Cell 140, 567–578.
Bobba, A., Canu, N., Atlante, A., Petragallo, V., Calissano, P., Marra, E., 2002. Proteasome inhibitors prevent cytochrome c release during apoptosis but not in
excitotoxic death of cerebellar granule neurons. FEBS Lett. 515, 8–12.
Bonde, C., Noraberg, J., Noer, H., Zimmer, J., 2005. Ionotropic glutamate receptors
andglutamatetransportersareinvolvedinnecroticneuronalcelldeathinduced
by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience
136, 779–794.
Boutet, S.C., Disatnik, M.H., Chan, L.S., Iori, K., Rando, T.A., 2007. Regulation of Pax3
by proteasomal degradation of monoubiquitinated protein in skeletal muscle
progenitors. Cell 130, 349–362.
Boyce, M., Yuan, J., 2006. Cellular response to endoplasmic reticulum stress: a
matter of life or death. Cell Death Differ. 13, 363–373.
Braun,B.C.,Glickman,M.,Kraft,R.,Dahlmann,B.,Kloetzel,P.M.,Finley,D.,Schmidt,
M., 1999. The base of the proteasome regulatory particle exhibits chaperonelike activity. Nature Cell Biol. 1, 221–226.
Brooks, P., Murray, R.Z., Mason, G.G., Hendil, K.B., Rivett, A.J., 2000. Association of
immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352 (Pt. 3)
611–615.
Broughton, B.R., Reutens, D.C., Sobey, C.G., 2009. Apoptotic mechanisms after
cerebral ischemia. Stroke 40, e331–e339.
Buchan, A.M., Li, H., Blackburn, B., 2000. Neuroprotection achieved with a novel
proteasomeinhibitorwhichblocksNF-kappaBactivation.Neuroreport11,427–
430.
Cajigas, I.J., Will, T., Schuman, E.M., 2010. Protein homeostasis and synaptic plasticity. EMBO J. 29, 2746–2752.
Caldeira, M.V., Curcio, M., Leal, G., Salazar, I.L., Mele, M., Santos, A.R., Melo, C.V.,
Pereira, P., Canzoniero, L.M., Duarte, C.B., 2013. Excitotoxic stimulation downregulatestheubiquitin-proteasomesystemthroughactivationofNMDAreceptors in cultured hippocampal neurons. Biochim. Biophys. Acta 1832, 263–274.
Calfon,M.,Zeng,H.,Urano,F.,Till,J.H.,Hubbard,S.R.,Harding,H.P.,Clark,S.G.,Ron,
D., 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by
processing the XBP-1 mRNA. Nature 415, 92–96.
Camins, A., Verdaguer, E., Folch, J., Pallas, M., 2006. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 12, 135–148.
Cartier, A.E., Djakovic, S.N., Salehi, A., Wilson, S.M., Masliah, E., Patrick, G.N., 2009.
Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. J. Neurosci. 29, 7857–7868.
Chen, P.C., Bhattacharyya, B.J., Hanna, J., Minkel, H., Wilson, J.A., Finley, D., Miller,
R.J., Wilson, S.M., 2011. Ubiquitin homeostasis is critical for synaptic development and function. J. Neurosci. 31, 17505–17513.
Chen, X., Kintner, D.B., Baba, A., Matsuda, T., Shull, G.E., Sun, D., 2010. Protein
aggregationinneuronsfollowingOGD:aroleforNa+andCa2+ionicdysregulation. J. Neurochem. 112, 173–182.
Chernorudskiy, A.L., Gainullin, M.R., 2013. Ubiquitin system: direct effects join the
signaling. Sci. Signal. 6, e22.
Choi,A.M.,Ryter,S.W.,Levine,B.,2013.Autophagyinhumanhealthanddisease.N.
Engl. J. Med. 368, 1845–1846.
Choi, D.W., Maulucci-Gedde, M., Kriegstein, A.R., 1987. Glutamate neurotoxicity in
cortical cell culture. J. Neurosci. 7, 357–368.
Chu, J., Hong, N.A., Masuda, C.A., Jenkins, B.V., Nelms, K.A., Goodnow, C.C., Glynne,
R.J.,Wu,H.,Masliah,E.,Joazeiro,C.A.,Kay,S.A.,2009.Amouseforwardgenetics
screenidentifiesLISTERINasanE3ubiquitinligaseinvolvedinneurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 106, 2097–2103.
Ciechanover, A., 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79,
13–21.
Ciechanover, A., Heller, H., Elias, S., Haas, A.L., Hershko, A., 1980. ATP-dependent
conjugation of reticulocyte proteins with the polypeptide required for protein
degradation. Proc. Natl. Acad. Sci. U.S.A. 77, 1365–1368.
Ciechanover,A.,Hod,Y.,Hershko,A.,1978.Aheat-stablepolypeptidecomponentof
an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys.
Res. Commun. 81, 1100–1105.
Colledge,M.,Snyder,E.M.,Crozier,R.A.,Soderling,J.A.,Jin,Y.,Langeberg,L.K.,Lu,H.,
Bear, M.F., Scott, J.D., 2003. Ubiquitination regulates PSD-95 degradation and
AMPA receptor surface expression. Neuron 40, 595–607.
Coyle,J.T.,Puttfarcken,P.,1993.Oxidativestress,glutamate,andneurodegenerative
disorders. Science 262, 689–695.
Crimmins,S.,Jin,Y.,Wheeler,C.,Huffman,A.K.,Chapman,C.,Dobrunz,L.E.,Levey,A.,
Roth,K.A.,Wilson,J.A.,Wilson,S.M.,2006.Transgenicrescueofataxiamicewith
neuronal-specific expression of ubiquitin-specific protease 14. J. Neurosci. 26,
11423–11431.
Cuervo,A.M.,Palmer,A.,Rivett,A.J.,Knecht,E.,1995.Degradationofproteasomesby
lysosomes in rat liver. Eur. J. Biochem. 227, 792–800.
da Fonseca, P.C., He, J., Morris, E.P., 2012. Molecular model of the human 26S
proteasome. Mol. Cell 46, 54–66.
daFonseca,P.C.,Morris,E.P.,2008.Structureofthehuman26Sproteasome:subunit
radialdisplacementsopen thegateintotheproteolyticcore.J. Biol.Chem.283,
23305–23314.
Dahlmann, B., Ruppert, T., Kuehn, L., Merforth, S., Kloetzel, P.M., 2000. Different
proteasomesubtypesinasingletissueexhibitdifferentenzymaticproperties.J.
Mol. Biol. 303, 643–653.
Dantuma,N.P.,Groothuis,T.A.,Salomons,F.A.,Neefjes,J.,2006.Adynamicubiquitin
equilibrium couples proteasomal activity to chromatin remodeling. J. Cell Biol.
173, 19–26.
Dantuma, N.P., Lindsten, K., Glas, R., Jellne, M., Masucci, M.G., 2000. Short-lived
green fluorescent proteins for quantifying ubiquitin/proteasome-dependent
proteolysis in living cells. Nat. Biotechnol. 18, 538–543.
de Bie, P., Ciechanover, A., 2011. Ubiquitinationof E3ligases: self-regulation of the
ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death
Differ. 18, 1393–1402.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 64
( 8.0.0.2542.94065913 PDF Extractor SDK EVAL VERSION)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0265
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0265
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0270
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0270
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0270
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0280
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0280
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0285
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0285
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0295
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0295
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0300
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0300
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0305
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0305
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0310
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0310
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0310
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0315
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0315
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0315
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0325
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0325
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0330
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0330
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0335
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0335
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0340
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0340
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0340
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0345
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0345
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0355
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0355
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0360
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0360
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0365
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0365
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0370
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0370
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0370
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0380
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0380
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0380
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0395
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0395
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0400
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0400
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0405
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0405
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0410
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0410
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0425
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0425
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0430
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0430
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0430
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0460
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0460
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0460
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0470
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0470
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0475
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0475
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0490
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0490
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0495
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0495
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0500
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0500
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0505
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0505
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0510
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0510
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0515
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0515
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0520
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0520
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0520
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0530
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0530
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0535
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0535
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0535
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0540
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0540
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0545
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0545
DeGracia,D.J.,Jamison,J.T.,Szymanski,J.J.,Lewis,M.K.,2008.Translationarrestand
ribonomics in post-ischemic brain: layers and layers of players. J. Neurochem.
106, 2288–2301.
DeGracia, D.J., Montie, H.L., 2004. Cerebral ischemia and the unfolded protein
response. J. Neurochem. 91, 1–8.
DeGracia, D.J., Rudolph, J., Roberts, G.G., Rafols, J.A., Wang, J., 2007. Convergence of
stress granules and protein aggregates in hippocampal cornu ammonis 1 at
later reperfusion following global brain ischemia. Neuroscience 146, 562–572.
Dennissen, F.J., Kholod, N., van Leeuwen, F.W., 2012. The ubiquitin proteasome
system in neurodegenerative diseases: culprit, accomplice or victim? Prog.
Neurobiol. 96, 190–207.
Deshaies, R.J., Joazeiro, C.A., 2009. RING domain E3 ubiquitin ligases. Annu. Rev.
Biochem. 78, 399–434.
Diaz-Hernandez, M., Hernandez, F., Martin-Aparicio, E., Gomez-Ramos, P., Moran,
M.A.,Castano, J.G.,Ferrer,I.,Avila,J., Lucas,J.J.,2003.Neuronalinduction ofthe
immunoproteasome in Huntington’s disease. J. Neurosci. 23, 11653–11661.
Dimova,N.V.,Hathaway,N.A.,Lee,B.H.,Kirkpatrick,D.S.,Berkowitz,M.L.,Gygi,S.P.,
Finley, D., King, R.W., 2012. APC/C-mediated multiple monoubiquitylation
provides an alternative degradation signal for cyclin B1. Nature Cell Biol. 14,
168–176.
Ding, Q., Dimayuga, E., Markesbery, W.R., Keller, J.N., 2006. Proteasome inhibition
induces reversible impairments in protein synthesis. FASEB J. 20, 1055–1063.
Djakovic, S.N., Marquez-Lona, E.M., Jakawich, S.K., Wright, R., Chu, C., Sutton, M.A.,
Patrick, G.N., 2012. Phosphorylation of Rpt6 regulates synaptic strength in
hippocampal neurons. J. Neurosci. 32, 5126–5131.
Djakovic, S.N., Schwarz, L.A., Barylko, B., DeMartino, G.N., Patrick, G.N., 2009.
Regulation of the proteasome by neuronal activity and calcium/calmodulindependent protein kinase II. J. Biol. Chem. 284, 26655–26665.
Doeppner,T.R.,Doehring,M.,Bretschneider,E.,Zechariah,A.,Kaltwasser,B.,Muller,
B.,Koch,J.C.,Bahr,M.,Hermann,D.M.,Michel,U.,2013.MicroRNA-124protects
against focal cerebral ischemia via mechanisms involving Usp14-dependent
REST degradation. Acta Neuropathol. 126, 251–265.
Doeppner, T.R., Mlynarczuk-Bialy, I., Kuckelkorn, U., Kaltwasser, B., Herz, J., Hasan,
M.R., Hermann, D.M., Bahr, M., 2012. The novel proteasome inhibitor BSc2118
protectsagainstcerebralischaemiathroughHIF1Aaccumulationandenhanced
angioneurogenesis. Brain 135, 3282–3297.
Dong, C., Upadhya, S.C., Ding, L., Smith, T.K., Hegde, A.N., 2008. Proteasome inhibition enhances the induction and impairs the maintenance of late-phase longterm potentiation. Learn. Mem. 15, 335–347.
Doyle, K.P., Simon, R.P., Stenzel-Poore, M.P., 2008. Mechanisms of ischemic brain
damage. Neuropharmacology 55, 310–318.
Duttler,S.,Pechmann,S.,Frydman,J.,2013.Principlesofcotranslationalubiquitination and quality control at the ribosome. Mol. Cell 50, 379–393.
Ebert, D.H., Greenberg, M.E., 2013. Activity-dependent neuronal signalling and
autism spectrum disorder. Nature 493, 327–337.
Egerer, K., Kuckelkorn, U., Rudolph, P.E., Ruckert, J.C., Dorner, T., Burmester, G.R.,
Kloetzel, P.M., Feist, E., 2002. Circulating proteasomes are markers of cell
damage and immunologic activity in autoimmune diseases. J. Rheumatol. 29,
2045–2052.
Ehlers, M.D., 2003. Activity level controls postsynaptic composition and signaling
via the ubiquitin-proteasome system. Nat. Neurosci. 6, 231–242.
Elsasser, S., Chandler-Militello, D., Muller, B., Hanna, J., Finley, D., 2004. Rad23 and
Rpn10serveasalternativeubiquitinreceptorsfortheproteasome.J.Biol.Chem.
279, 26817–26822.
Elsasser,S.,Gali,R.R.,Schwickart,M.,Larsen,C.N.,Leggett,D.S.,Muller,B.,Feng,M.T.,
Tubing, F., Dittmar, G.A.G., Finley, D., 2002. Proteasome subunit Rpn1 binds
ubiquitin-like protein domains. Nat. Cell Biol. 4, 725–730.
Erdal, H., Berndtsson, M., Castro, J., Brunk, U., Shoshan, M.C., Linder, S., 2005.
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 102, 192–197.
Fang,S.,Weissman,A.M.,2004.Afieldguidetoubiquitylation.CellMol.LifeSci.61,
1546–1561.
Farooqui, A.A., Horrocks, L.A., 1994. Involvement of glutamate receptors, lipases,
and phospholipases in long-term potentiation and neurodegeneration. J. Neurosci. Res. 38, 6–11.
Fedorova, O.A., Moiseeva, T.N., Nikiforov, A.A., Tsimokha, A.S., Livinskaya, V.A.,
Hodson, M., Bottrill, A., Evteeva, I.N., Ermolayeva, J.B., Kuznetzova, I.M., Turoverov
, K.K., Eperon, I., Barlev, N.A., 2011. Proteomic analysis of the 20S
proteasome (PSMA3)-interacting proteins reveals a functional link between
the proteasome and mRNA metabolism. Biochem. Biophys. Res. Commun. 416,
258–265.
Feng, P., Ma, Y., Vogel, G.W., 2001. The critical window of brain development from
susceptive to insusceptive. Effects of clomipramine neonatal treatment on
sexual behavior. Brain Res. Dev. Brain Res. 129, 107–110.
Ferreira, I.L., Duarte, C.B., Carvalho, A.P., 1996. Ca2+ influx through glutamate
receptor-associatedchannelsinretinacellscorrelateswithneuronalcelldeath.
Eur. J. Pharmacol. 302, 153–162.
Ferreira,I.L.,Duarte,C.B.,Carvalho,A.P.,1998.Kainate-inducedretinaamacrine-like
cell damage is mediated by AMPA receptors. Neuroreport 9, 3471–3475.
Finley, D., Ulrich, H.D., Sommer, T., Kaiser, P., 2012. The ubiquitin-proteasome
system of Saccharomyces cerevisiae. Genetics 192, 319–360.
Ge, P., Luo, Y., Liu, C.L., Hu, B., 2007. Protein aggregation and proteasome dysfunction after brain ischemia. Stroke 38, 3230–3236.
Ge, P., Zhang,F., Zhao,J., Liu,C., Sun,L., Hu,B., 2012. Protein degradation pathways
after brain ischemia. Curr. Drug Targets 13, 159–165.
Glickman,M.H.,Ciechanover,A.,2002.Theubiquitin-proteasomeproteolyticpathway
: destruction for the sake of construction. Physiol. Rev. 82, 373–428.
Goldberg, A.L., Cascio, P., Saric, T., Rock, K.L., 2002. The importance of the proteasomeandsubsequentproteolyticstepsinthegenerationofantigenicpeptides.
Mol. Immunol. 39, 147–164.
Goldberg, M.P., Choi, D.W., 1993. Combined oxygen and glucose deprivation in
cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13, 3510–3524.
Goldstein, G., 1974. Isolation of bovine thymin: a polypeptide hormone of the
thymus. Nature 247, 11–14.
Goldstein, G., Scheid, M., Hammerling, U., Schlesinger, D.H., Niall, H.D., Boyse, E.A.,
1975.Isolationofapolypeptidethathaslymphocyte-differentiatingproperties
and is probably represented universally in living cells. Proc. Natl. Acad. Sci.
U.S.A. 72, 11–15.
Gomes, J.R., Costa, J.T., Melo, C.V., Felizzi, F., Monteiro, P., Pinto, M.J., Inacio, A.R.,
Wieloch, T., Almeida, R.D., Graos, M., Duarte, C.B., 2012. Excitotoxicity downregulatesTrkB.FLsignalingandupregulatestheneuroprotectivetruncatedTrkB
receptors in cultured hippocampal and striatal neurons. J. Neurosci. 32, 4610–
4622.
Gomes, J.R., Lobo, A.C., Melo, C.V., Inacio, A.R., Takano, J., Iwata, N., Saido, T.C., de
Almeida, L.P., Wieloch, T., Duarte, C.B., 2011. Cleavage of the vesicular GABA
transporter under excitotoxic conditions is followed by accumulation of the
truncated transporter in nonsynaptic sites. J. Neurosci. 31, 4622–4635.
Gould,E.,Cameron,H.A.,McEwen,B.S.,1994.BlockadeofNMDAreceptorsincreases
cell death and birth in the developing rat dentate gyrus. J. Comp. Neurol. 340,
551–565.
Grabbe, C., Husnjak, K., Dikic, I., 2011. The spatial and temporal organization of
ubiquitin networks. Nature reviews. Mol. Cell. Biol. 12, 295–307.
Greer,P.L.,Hanayama,R.,Bloodgood,B.L.,Mardinly,A.R.,Lipton,D.M.,Flavell,S.W.,
Kim, T.K., Griffith, E.C., Waldon, Z., Maehr, R., Ploegh, H.L., Chowdhury, S.,
Worley, P.F., Steen, J., Greenberg, M.E., 2010. The Angelman Syndrome protein
Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704–
716.
Grewer, C., Gameiro, A., Zhang, Z., Tao, Z., Braams, S., Rauen, T., 2008. Glutamate
forward and reverse transport: from molecular mechanism to transportermediated release after ischemia. IUBMB Life 60, 609–619.
Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H.D., Huber, R., 1997.
Structure of 20S proteasome from yeast at 2.4A ˚ resolution. Nature 386, 463–
471.
Groothuis, T.A., Dantuma, N.P., Neefjes, J., Salomons, F.A., 2006. Ubiquitin crosstalk
connecting cellular processes. Cell Div. 1, 21.
Gu, L., Liu, X., Yang, Y., Luo, D., Zheng, X., 2010. ASICs aggravate acidosis-induced
injuries during ischemic reperfusion. Neurosci. Lett. 479, 63–68.
Guerrero, C., Tagwerker, C., Kaiser, P., Huang, L., 2006. An integrated mass spectrometry-based proteomic approach: quantitative analysis of tandem affinitypurified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S
proteasome-interacting network. Mol. Cell. Proteomics 5, 366–378.
Guterman, A., Glickman, M.H., 2004. Complementary roles for Rpn11 and Ubp6 in
deubiquitination and proteolysis by the proteasome. J. Biol. Chem. 279, 1729–
1738.
Hamilton, A.M., Oh, W.C., Vega-Ramirez, H., Stein, I.S., Hell, J.W., Patrick, G.N., Zito,
K.,2012.Activity-dependentgrowthofnewdendriticspinesisregulatedbythe
proteasome. Neuron 74, 1023–1030.
Hamilton,A.M.,Zito,K.,2013.Breakingitdown:theubiquitinproteasomesystemin
neuronal morphogenesis. Neural Plast. 2013, 196848.
Hansen,A.J.,1985.Effectofanoxiaoniondistributioninthebrain.Physiol.Rev.65,
101–148.
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima,
R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., Mizushima, N., 2006.
Suppression of basal autophagy in neural cells causes neurodegenerative
disease in mice. Nature 441, 885–889.
Harding, H.P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., Ron, D., 2000.
Regulated translation initiation controls stress-induced gene expression in
mammalian cells. Mol. Cell 6, 1099–1108.
Hardingham,G.E.,Bading,H.,2003.TheYinandYangofNMDAreceptorsignalling.
Trends Neurosci. 26, 81–89.
Hardingham, G.E., Fukunaga, Y., Bading, H., 2002. Extrasynaptic NMDARs oppose
synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat.
Neurosci. 5, 405–414.
Harvey, B.K., Airavaara, M., Hinzman, J., Wires, E.M., Chiocco, M.J., Howard, D.B.,
Shen, H., Gerhardt, G., Hoffer, B.J., Wang, Y., 2011. Targeted over-expression of
glutamatetransporter1(GLT-1)reducesischemicbraininjuryinaratmodelof
stroke. PLoS One 6, e22135.
Hayashi, T., Saito, A., Okuno, S., Ferrand-Drake, M., Dodd, R.L., Chan, P.H., 2004.
Oxidative injury to the endoplasmic reticulum in mouse brains after transient
focal ischemia. Neurobiol. Dis. 15, 229–239.
Hayashi,T., Saito,A., Okuno, S., Ferrand-Drake,M., Dodd, R.L.,Nishi,T., Maier,C.M.,
Kinouchi,H.,Chan,P.H.,2003.Oxidativedamagetotheendoplasmicreticulum
is implicated in ischemic neuronal cell death. J. Cereb. Blood Flow Metab. 23,
1117–1128.
Hayashi, T., Takada, K., Matsuda, M., 1992. Post-transient ischemia increase in
ubiquitin conjugates in the early reperfusion. Neuroreport 3, 519–520.
Heales, S.J., Bolanos, J.P., Stewart, V.C., Brookes, P.S., Land, J.M., Clark, J.B., 1999.
Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta
1410, 215–228.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 65
(DEMO VERSION PDF Extractor SDK 8.0.0.2542.1794029791)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0550
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0550
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0560
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0560
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0570
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0570
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0575
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0575
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0580
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0580
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0580
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0585
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0585
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0590
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0590
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0595
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0595
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0595
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0600
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0600
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0600
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0605
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0605
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0610
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0610
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0610
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0615
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0615
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0615
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0620
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0620
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0620
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0625
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0625
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0630
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0630
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0630
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0635
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0635
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0640
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0640
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0640
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0645
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0645
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0645
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0650
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0650
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0650
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0655
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0655
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0655
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0660
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0660
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0665
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0665
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0670
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0670
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0670
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0675
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0675
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0680
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0680
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0680
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0685
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0685
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0685
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0690
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0690
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0690
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0695
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0695
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0695
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0700
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0700
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0700
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0705
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0705
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0710
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0710
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0715
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0715
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0715
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0720
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0720
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0725
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0725
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0725
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0730
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0730
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0730
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0735
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0735
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0740
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0740
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0740
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0745
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0745
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0745
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0750
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0750
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0755
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0755
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0760
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0760
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0760
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0765
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0765
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0765
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0770
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0770
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0775
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0775
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0780
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0780
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0785
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0785
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0790
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0790
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0790
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0795
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0795
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0795
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0800
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0800
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0800
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0805
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0805
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0805
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0810
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0810
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0815
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0820
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0820
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0820
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0825
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0825
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0830
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0830
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0835
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0835
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0835
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0840
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0840
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0845
Hershko, A., Ciechanover, A., 1998. The ubiquitin system. Annu. Rev. Biochem. 67,
425–479.
Hershko, A., Heller, H., Elias, S., Ciechanover, A., 1983. Components of ubiquitinprotein ligase system. Resolution, affinity purification, and role in protein
breakdown. J. Biol. Chem. 258, 8206–8214.
Hertz, L., 2008. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55, 289–309.
Hochrainer, K., Jackman, K., Anrather, J., Iadecola, C., 2012. Reperfusion rather than
ischemia drives the formation of ubiquitin aggregates after middle cerebral
artery occlusion. Stroke 43, 2229–2235.
Hofmeijer, J., van Putten, M.J., 2012. Ischemic cerebral damage: an appraisal of
synaptic failure. Stroke 43, 607–615.
Hoppe,T.,2005.MultiubiquitylationbyE4enzymes:‘onesize’doesn’tfitall.Trends
Biochem. Sci. 30, 183–187.
Hou, Q., Gilbert, J., Man, H.Y., 2011. Homeostatic regulation of AMPA receptor
traffickinganddegradationbylight-controlledsingle-synapticactivation.Neuron 72, 806–818.
Hu, B.R., Janelidze, S., Ginsberg, M.D., Busto, R., Perez-Pinzon, M., Sick, T.J., Siesjo,
B.K., Liu, C.L., 2001. Protein aggregation after focal brain ischemia and reperfusion. J. Cereb. Blood Flow Metab. 21, 865–875.
Hu,B.R.,Martone,M.E.,Jones,Y.Z.,Liu,C.L.,2000.Proteinaggregationaftertransient
cerebral ischemia. J. Neurosci. 20, 3191–3199.
Huang,Q.,Wang,H.,Perry,S.W.,Figueiredo-Pereira,M.E.,2013.Negativeregulation
of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit
upon mitochondrial dysfunction in neurons. J. Biol. Chem. 288, 12161–12174.
Hung, A.Y., Sung, C.C., Brito, I.L., Sheng, M., 2010. Degradation of postsynaptic
scaffold GKAP and regulation of dendritic spine morphology by the TRIM3
ubiquitin ligase in rat hippocampal neurons. PLoS One 5, e9842.
Husnjak,K.,Elsasser,S.,Zhang,N.,Chen,X.,Randles,L.,Shi,Y.,Hofmann,K.,Walters,
K.J., Finley, D., Dikic, I., 2008. Proteasome subunit Rpn13 is a novel ubiquitin
receptor. Nature 453, 481–488.
Ide,T.,Takada,K.,Qiu,J.H.,Saito,N.,Kawahara,N.,Asai,A.,Kirino,T.,1999.Ubiquitin
stress response in postischemic hippocampal neurons under nontolerant and
tolerant conditions. J. Cereb. Blood Flow Metab. 19, 750–756.
Jia, J., Verma, S., Nakayama, S., Quillinan, N., Grafe, M.R., Hurn, P.D., Herson, P.S.,
2011. Sex differences in neuroprotection provided by inhibition of TRPM2
channels following experimental stroke. J. Cereb. Blood Flow Metab. 31,
2160–2168.
Jiang, X., Litkowski, P.E., Taylor, A.A., Lin, Y., Snider, B.J., Moulder, K.L., 2010. A role
fortheubiquitin-proteasomesysteminactivity-dependentpresynapticsilencing. J. Neurosci. 30, 1798–1809.
Jin, J., Li, X., Gygi, S.P., Harper, J.W., 2007. Dual E1 activation systems for ubiquitin
differentially regulate E2 enzyme charging. Nature 447, 1135–1138.
Jurd,R.,Thornton,C.,Wang,J.,Luong,K.,Phamluong,K.,Kharazia,V.,Gibb,S.L.,Ron,
D., 2008. Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-
aspartate receptor NR2B subunit in a phosphorylation-dependent manner. J.
Biol. Chem. 283, 301–310.
Kamikubo,T.,Hayashi,T.,1996.Changesinproteasomeactivityfollowingtransient
ischemia. Neurochem. Int. 28, 209–212.
Karpova, A., Mikhaylova, M., Bera, S., Bar, J., Reddy, P.P., Behnisch, T., Rankovic, V.,
Spilker,C.,Bethge,P.,Sahin,J.,Kaushik,R.,Zuschratter,W.,Kahne,T.,Naumann,
M., Gundelfinger, E.D., Kreutz, M.R., 2013. Encoding and transducing the synapticorextrasynapticoriginofNMDAreceptorsignalstothenucleus.Cell152,
1119–1133.
Kato, A., Rouach, N., Nicoll, R.A., Bredt, D.S., 2005. Activity-dependent NMDA
receptor degradation mediated by retrotranslocation and ubiquitination. Proc.
Natl. Acad. Sci. U.S.A. 102, 5600–5605.
Kaufman,A.M.,Milnerwood,A.J.,Sepers,M.D.,Coquinco,A.,She,K.,Wang,L.,Lee,H.,
Craig, A.M., Cynader, M., Raymond, L.A., 2012. Opposing roles of synaptic and
extrasynaptic NMDA receptor signaling in cocultured striatal and cortical
neurons. J. Neurosci. 32, 3992–4003.
Keller, J.N., Huang, F.F., Zhu, H., Yu, J., Ho, Y.S., Kindy, T.S., 2000. Oxidative stressassociated impairment of proteasome activity during ischemia-reperfusion
injury. J. Cereb. Blood Flow Metab. 20, 1467–1473.
Keller,J.N.,Markesbery,W.R.,2000.Proteasomeinhibitionresultsinincreasedpoly-
ADP-ribosylation:implicationsforneurondeath.J.Neurosci. Res.61,436–442.
Kim, W., Bennett, E.J., Huttlin, E.L., Guo, A., Li, J., Possemato, A., Sowa, M.E., Rad, R.,
Rush, J., Comb, M.J., Harper, J.W., Gygi, S.P., 2011. Systematic and quantitative
assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325–340.
Kimelberg,H.K.,Mongin,A.A.,1998.Swelling-activatedreleaseofexcitatoryamino
acids in the brain: relevance for pathophysiology. Contrib. Nephrol. 123, 240–
257.
Kirino, T., 1982. Delayed neuronal death in the gerbil hippocampus following
ischemia. Brain Res. 239, 57–69.
Koegl,M.,Hoppe,T.,Schlenker,S.,Ulrich,H.D.,Mayer,T.U.,Jentsch,S.,1999.Anovel
ubiquitinationfactor, E4,is involvedinmultiubiquitinchain assembly. Cell 96,
635–644.
Kohler, A., Cascio, P., Leggett, D.S., Woo, K.M., Goldberg, A.L., Finley, D., 2001. The
axial channel of the proteasome core particle is gated by the Rpt2 ATPase and
controls both substrate entry and product release. Mol. Cell 7, 1143–1152.
Kohno, K., Higuchi, T., Ohta, S., Kumon, Y., Sakaki, S., 1997. Neuroprotective nitric
oxide synthase inhibitor reduces intracellular calcium accumulation following
transient global ischemia in the gerbil. Neurosci. Lett. 224, 17–20.
Kokame, K., Agarwala, K.L., Kato, H., Miyata, T., 2000. Herp, a new ubiquitin-like
membraneproteininducedbyendoplasmicreticulumstress.J.Biol.Chem.275,
32846–32853.
Kokame, K., Kato, H., Miyata, T., 2001. Identification of ERSE-II, a new cis-acting
element responsible for the ATF6-dependent mammalian unfolded protein
response. J. Biol. Chem. 276, 9199–9205.
Komander, D., Clague, M.J., Urbe, S., 2009. Breaking the chains: structure and
function of the deubiquitinases. Nature reviews. Mol. Cell. Biol. 10, 550–563.
Komatsu,M.,Waguri,S.,Chiba,T.,Murata,S.,Iwata,J.,Tanida,I.,Ueno,T.,Koike,M.,
Uchiyama, Y., Kominami, E., Tanaka, K., 2006. Loss of autophagy in the central
nervous system causes neurodegeneration in mice. Nature 441, 880–884.
Korb, E., Wilkinson, C.L., Delgado, R.N., Lovero, K.L., Finkbeiner, S., 2013. Arc in the
nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity. Nat. Neurosci. 16, 874–883.
Kostandy, B.B., 2012. The role of glutamatein neuronalischemic injury: the role of
spark in fire. Neurol. Sci. 33, 223–237.
Koulich, E., Li, X., DeMartino, G.N., 2008. Relative structural and functional roles of
multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 19, 1072–1082.
Kulathu, Y., Komander, D., 2012. Atypical ubiquitylation—the unexplored world of
polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell. Biol. 13,
508–523.
Kumar, R., Azam, S., Sullivan, J.M., Owen, C., Cavener, D.R., Zhang, P., Ron, D.,
Harding, H.P., Chen, J.J., Han, A., White, B.C., Krause, G.S., DeGracia, D.J.,
2001. Brain ischemia and reperfusion activates the eukaryotic initiation factor
2alpha kinase, PERK. J. Neurochem. 77, 1418–1421.
Kumar,R.,Krause,G.S.,Yoshida,H.,Mori,K.,DeGracia,D.J.,2003.Dysfunctionofthe
unfolded protein response during global brain ischemia and reperfusion. J.
Cereb. Blood Flow Metab. 23, 462–471.
Lam, Y.A., Lawson, T.G., Velayutham, M., Zweier, J.L., Pickart, C.M., 2002. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature
416, 763–767.
Lamark, T., Kirkin, V., Dikic, I., Johansen, T., 2009. NBR1 and p62 as cargo receptors
for selective autophagy of ubiquitinated targets. Cell Cycle 8, 1986–1990.
Lander, G.C., Estrin, E., Matyskiela, M.E., Bashore, C., Nogales, E., Martin, A., 2012.
Complete subunit architecture of the proteasome regulatory particle. Nature
482, 186–191.
Lavabre-Bertrand,T.,Henry,L.,Carillo,S.,Guiraud,I.,Ouali,A.,Dutaud,D.,Aubry,L.,
Rossi, J.F., Bureau, J.P., 2001. Plasma proteasome level is a potential marker in
patients with solid tumors and hemopoietic malignancies. Cancer 92, 2493–
2500.
Lee, B.H., Lee, M.J., Park, S., Oh, D.C., Elsasser, S., Chen, P.C., Gartner, C., Dimova, N.,
Hanna, J., Gygi, S.P., Wilson, S.M., King, R.W., Finley, D., 2010. Enhancement of
proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179–
184.
Lee, J.M., Zipfel, G.J., Choi, D.W., 1999. The changing landscape of ischaemic brain
injury mechanisms. Nature 399, A7–A14.
Lee,P.C.,Dodart,J.C.,Aron,L.,Finley,L.W.,Bronson,R.T.,Haigis,M.C.,Yankner,B.A.,
Harper, J.W., 2013. Altered social behavior and neuronal development in mice
lacking the Uba6-Use1 ubiquitin transfer system. Mol. Cell 50, 172–184.
Leggett, D.S., Hanna, J., Borodovsky, A., Crosas, B., Schmidt, M., Baker, R.T., Walz, T.,
Ploegh, H., Finley, D., 2002. Multiple associated proteins regulate proteasome
structure and function. Mol. Cell 10, 495–507.
Leveille,F.,Papadia,S.,Fricker,M.,Bell,K.F.,Soriano,F.X.,Martel,M.A.,Puddifoot,C.,
Habel,M.,Wyllie,D.J.,Ikonomidou,C.,Tolkovsky,A.M.,Hardingham,G.E.,2010.
Suppressionoftheintrinsicapoptosispathwaybysynapticactivity.J.Neurosci.
30, 2623–2635.
Li,Z.Y.,Liu,B.,Yu,J.,Yang,F.W.,Luo,Y.N.,Ge,P.F.,2012.Ischaemicpostconditioning
rescues brain injury caused by focal ischaemia/reperfusion via attenuation of
protein oxidization. J. Int. Med. Res. 40, 954–966.
Liang,J.,Yao,J.,Wang,G.,Wang,Y.,Wang,B.,Ge,P.,2012.Ischemicpostconditioning
protects neuronal death caused by cerebral ischemia and reperfusion via
attenuating protein aggregation. Int. J. Med. Sci. 9, 923–932.
Lin, A., Hou, Q., Jarzylo, L., Amato, S., Gilbert, J., Shang, F., Man, H.Y., 2011. Nedd4-
mediated AMPA receptor ubiquitination regulates receptor turnover and trafficking. J. Neurochem. 119, 27–39.
Lindsten, K., de Vrij, F.M., Verhoef, L.G., Fischer, D.F., van Leeuwen, F.W., Hol, E.M.,
Masucci, M.G., Dantuma, N.P., 2002. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157, 417–427.
Lipski,J.,Park,T.I.,Li,D.,Lee,S.C.,Trevarton,A.J.,Chung,K.K.,Freestone,P.S.,Bai,J.Z.,
2006. Involvement of TRP-like channels in the acute ischemic response of
hippocampal CA1 neurons in brain slices. Brain Res. 1077, 187–199.
Lipton, P., 1999.Ischemic cell death in brain neurons.Physiol. Rev.79, 1431–1568.
Liu, B., Liao, M., Mielke, J.G., Ning, K., Chen, Y., Li, L., El-Hayek, Y.H., Gomez, E.,
Zukin, R.S., Fehlings, M.G., Wan, Q., 2006. Ischemic insults direct glutamate
receptor subunit 2-lacking AMPA receptors to synaptic sites. J. Neurosci. 26,
5309–5319.
Liu, C., Gao, Y., Barrett, J., Hu, B., 2010. Autophagy and protein aggregation after
brain ischemia. J. Neurochem. 115, 68–78.
Liu, C.L., Ge, P., Zhang, F., Hu, B.R., 2005. Co-translational protein aggregation after
transient cerebral ischemia. Neuroscience 134, 1273–1284.
Liu, C.L., Martone, M.E., Hu, B.R., 2004. Protein ubiquitination in postsynaptic
densities after transient cerebral ischemia. J. Cereb. Blood Flow Metab. 24,
1219–1225.
Liu, C.W., Jacobson, A.D., 2013. Functions of the 19S complex in proteasomal
degradation. Trends Biochem. Sci. 38, 103–110.
Liu,H.,Li,W.,Ahmad,M.,Rose,M.E.,Miller,T.M.,Yu,M.,Chen,J.,Pascoe,J.L.,Poloyac,
S.M.,Hickey,R.W.,Graham,S.H.,2013.Increasedgenerationofcyclopentenone
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 66
(PDF Extractor SDK TRIAL VERSION)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0845
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0845
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0850
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0850
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0850
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0855
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0855
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0855
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0860
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0860
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0865
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0865
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0870
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0870
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0870
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0875
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0875
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0875
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0880
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0880
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0885
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0885
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0885
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0890
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0890
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0895
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0895
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0900
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0900
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0900
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0905
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0905
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0910
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0910
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0910
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0910
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0910
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0915
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0915
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0920
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0920
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0920
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0925
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0925
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0930
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0930
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0930
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0935
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0935
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0935
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0940
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0940
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0940
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0945
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0945
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0945
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0950
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0950
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0955
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0955
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0955
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0955
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0960
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0960
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0960
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0965
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0965
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0970
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0970
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0975
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0975
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0975
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0980
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0980
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0980
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0985
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0985
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0990
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0990
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0990
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0995
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0995
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref0995
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1000
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1000
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1005
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1005
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1005
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1010
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1010
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1010
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1015
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1020
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1020
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1020
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1025
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1030
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1030
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1035
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1035
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1040
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1040
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1045
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1050
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1055
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1055
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1055
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1060
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1065
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1065
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1070
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1075
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1075
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1080
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1080
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1085
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1085
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1085
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1090
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1090
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1090
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1095
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1100
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1105
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1110
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1115
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1115
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1120
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1120
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1120
prostaglandins after brain ischemia and their role in aggregation of ubiquitinated proteins in neurons. Neurotoxicol. Res. 24, 191–204.
Lobo, A.C., Gomes, J.R., Catarino, T., Mele, M., Fernandez, P., Inacio, A.R., Bahr, B.A.,
Santos, A.E., Wieloch, T., Carvalho, A.L., Duarte, C.B., 2011. Cleavage of the
vesicular glutamate transporters under excitotoxic conditions. Neurobiol.
Dis. 44, 292–303.
Loukissa, A., Cardozo, C., Altschuller-Felberg, C., Nelson, J.E., 2000. Control of LMP7
expression in human endothelial cells by cytokines regulating cellular and
humoral immunity. Cytokine 12, 1326–1330.
Love, K.R., Catic, A., Schlieker, C., Ploegh, H.L., 2007. Mechanisms, biology and
inhibitors of deubiquitinating enzymes. Nat. Chem. Biol. 3, 697–705.
Lu, L., Wang, H., 2012. Transient focal cerebral ischemia upregulates immunoproteasomal subunits. Cell. Mol. Neurobiol. 32, 965–970.
Lu, X., Rong, Y., Bi, R., Baudry, M., 2000. Calpain-mediated truncation of rat brain
AMPA receptors increases their Triton X-100 solubility. Brain Res. 863, 143–
150.
Lussier, M.P., Herring, B.E., Nasu-Nishimura, Y., Neutzner, A., Karbowski, M., Youle,
R.J., Nicoll, R.A., Roche, K.W., 2012. Ubiquitin ligase RNF167 regulates AMPA
receptor-mediated synaptic transmission. Proc. Natl. Acad. Sci. U.S.A. 109,
19426–19431.
Lussier, M.P., Nasu-Nishimura, Y., Roche, K.W., 2011. Activity-dependent ubiquitination of the AMPA receptor subunit GluA2. J. Neurosci. 31, 3077–3081.
Ma,Y.,Brewer,J.W.,Diehl,J.A.,Hendershot,L.M.,2002.Twodistinctstresssignaling
pathways converge upon the CHOP promoterduring the mammalianunfolded
protein response. J. Mol. Biol. 318, 1351–1365.
Maestre, C., Delgado-Esteban, M., Gomez-Sanchez, J.C., Bolanos, J.P., Almeida, A.,
2008. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J. 27, 2736–2745.
Magnusson, K., Wieloch, T., 1989. Impairment of protein ubiquitination may cause
delayed neuronal death. Neurosci. Lett. 96, 264–270.
Manev, H., Favaron, M., Guidotti, A., Costa, E., 1989. Delayed increase of Ca2+ influx
elicited by glutamate: role in neuronal death. Mol. Pharmacol. 36, 106–112.
Martel, M.A., Ryan, T.J., Bell, K.F., Fowler, J.H., McMahon, A., Al-Mubarak, B.,
Komiyama,N.H.,Horsburgh,K.,Kind,P.C.,Grant,S.G.,Wyllie,D.J.,Hardingham,
G.E.,2012.ThesubtypeofGluN2C-terminaldomaindeterminestheresponseto
excitotoxic insults. Neuron 74, 543–556.
Martinez-Sanchez,M.,Striggow,F.,Schroder,U.H.,Kahlert,S.,Reymann,K.G.,Reiser,
G., 2004. Na+ and Ca2+ homeostasis pathways, cell death and protection after
oxygen-glucose-deprivationinorganotypichippocampalslicecultures.Neuroscience 128, 729–740.
Meller, R., 2009. The role of the ubiquitin proteasome system in ischemia and
ischemic tolerance. Neuroscientist 15, 243–260.
Meller, R., Cameron, J.A., Torrey, D.J., Clayton, C.E., Ordonez, A.N., Henshall, D.C.,
Minami,M.,Schindler,C.K.,Saugstad,J.A.,Simon,R.P.,2006.Rapid degradation
of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic
tolerance in cultured neurons. J. Biol. Chem. 281, 7429–7436.
Meller, R., Thompson, S.J., Lusardi, T.A., Ordonez, A.N., Ashley, M.D., Jessick, V.,
Wang, W., Torrey, D.J., Henshall, D.C., Gafken, P.R., Saugstad, J.A., Xiong, Z.G.,
Simon, R.P., 2008. Ubiquitin proteasome-mediated synaptic reorganization: a
novel mechanism underlying rapid ischemic tolerance. J. Neurosci. 28, 50–59.
Melo, C.V., Okumoto, S., Gomes, J.R., Baptista, M.S., Bahr, B.A., Frommer, W.B.,
Duarte, C.B., 2013. Spatiotemporal resolution of BDNF neuroprotection against
glutamate excitotoxicity in cultured hippocampal neurons. Neuroscience 237,
66–86.
Miao, S., Chen, R., Ye, J., Tan, G.H., Li, S., Zhang, J., Jiang, Y.H., Xiong, Z.Q., 2013. The
AngelmansyndromeproteinUbe3aisrequiredforpolarizeddendritemorphogenesis in pyramidal neurons. J. Neurosci. 33, 327–333.
Mies, G., Paschen, W., Hossmann, K.A., 1990. Cerebral blood flow, glucose utilization
,regionalglucose,andATPcontentduringthematurationperiodofdelayed
ischemic injury in gerbil brain. J. Cereb. Blood Flow Metab. 10, 638–645.
Mishto, M., Bellavista, E., Ligorio, C., Textoris-Taube, K., Santoro, A., Giordano, M.,
D’Alfonso,S.,Listi,F.,Nacmias,B.,Cellini,E.,Leone,M.,Grimaldi,L.M.,Fenoglio,
C., Esposito, F., Martinelli-Boneschi, F., Galimberti, D., Scarpini, E., Seifert, U.,
Amato, M.P., Caruso, C., Foschini, M.P., Kloetzel, P.M., Franceschi, C., 2010.
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and
reducestherisktodevelopmultiplesclerosisinItalianfemalepopulation.PLoS
One 5, e9287.
Mishto, M., Bellavista, E., Santoro, A., Stolzing, A., Ligorio, C., Nacmias, B., Spazzafumo
, L., Chiappelli, M., Licastro, F., Sorbi, S., Pession, A., Ohm, T., Grune, T.,
Franceschi,C.,2006.ImmunoproteasomeandLMP2polymorphisminagedand
Alzheimer’s disease brains. Neurobiol. Aging 27, 54–66.
Monnerie, H., Hsu, F.C., Coulter, D.A., Le Roux, P.D., 2010. Role of the NR2A/2B
subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic
acid decarboxylasealteration in cortical GABAergic neurons in vitro. Neuroscience 171, 1075–1090.
Morimoto, T., Ide, T., Ihara, Y., Tamura, A., Kirino, T., 1996. Transient ischemia
depletes free ubiquitin in the gerbil hippocampal CA1 neurons. Am. J. Pathol.
148, 249–257.
Moskowitz, M.A., Lo, E.H., Iadecola, C., 2010. The science of stroke: mechanisms in
search of treatments. Neuron 67, 181–198.
Mouw, G., Zechel, J.L., Gamboa, J., Lust, W.D., Selman, W.R., Ratcheson, R.A., 2003.
Activation of caspase-12, an endoplasmic reticulum resident caspase, after
permanent focal ischemia in rat. Neuroreport 14, 183–186.
Myeku, N., Figueiredo-Pereira, M.E., 2011. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J. Biol. Chem. 286, 22426–22440.
Na, C.H., Jones, D.R., Yang, Y., Wang, X., Xu, Y., Peng, J., 2012. Synaptic protein
ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. J.
Proteome Res. 11, 4722–4732.
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B.A., Yuan, J., 2000.
Caspase-12mediatesendoplasmic-reticulum-specificapoptosisandcytotoxicity by amyloid-beta. Nature 403, 98–103.
Nakka, V.P., Gusain, A., Raghubir, R., 2010. Endoplasmic reticulum stress plays
critical role in brain damage after cerebral ischemia/reperfusion in rats. Neurotoxicol. Res. 17, 189–202.
Nathan, J.A., Kim, H.T., Ting, L., Gygi, S.P., Goldberg, A.L., 2013. Why do cellular
proteins linked to K63-polyubiquitin chains not associate with proteasomes?
EMBO J. 32, 552–565.
Neumar,R.W.,Meng,F.H.,Mills,A.M.,Xu,Y.A.,Zhang,C.,Welsh,F.A.,Siman,R.,2001.
Calpainactivityinthe ratbrain aftertransientforebrain ischemia. Exp. Neurol.
170, 27–35.
Noh, K.M., Yokota, H., Mashiko, T., Castillo, P.E., Zukin, R.S., Bennett, M.V., 2005.
Blockadeofcalcium-permeableAMPAreceptorsprotectshippocampalneurons
againstglobalischemia-induceddeath.Proc.Natl.Acad.Sci.U.S.A.102,12230–
12235.
Ogiso, Y., Tomida, A., Tsuruo, T., 2002. Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-
directed drugs. Cancer Res. 62, 5008–5012.
Olney,J.W.,1969.Brainlesions,obesity,andotherdisturbancesinmicetreatedwith
monosodium glutamate. Science 164, 719–721.
Osada, N., Kosuge, Y., Ishige, K., Ito, Y., 2010. Characterization of neuronal and
astroglialresponsestoERstressinthehippocampalCA1areainmicefollowing
transient forebrain ischemia. Neurochem. Int. 57, 1–7.
Ouyang, Y.B., Xu, L., Giffard, R.G., 2005. Geldanamycin treatment reduces delayed
CA1 damage in mouse hippocampal organotypic cultures subjected to oxygen
glucose deprivation. Neurosci. Lett. 380, 229–233.
Papadia,S., Soriano,F.X., Leveille, F., Martel, M.A.,Dakin, K.A.,Hansen, H.H.,Kaindl,
A.,Sifringer,M.,Fowler,J.,Stefovska,V.,McKenzie,G.,Craigon,M.,Corriveau,R.,
Ghazal, P., Horsburgh, K., Yankner, B.A., Wyllie, D.J., Ikonomidou, C., Hardingham
, G.E., 2008. Synaptic NMDA receptor activity boosts intrinsic antioxidant
defenses. Nat. Neurosci. 11, 476–487.
Papouin, T., Ladepeche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L.,
Pollegioni, L., Mothet, J.P., Oliet, S.H., 2012. Synaptic and extrasynaptic NMDA
receptors are gated by different endogenous coagonists. Cell 150, 633–646.
Park, H.K., Chu, K., Jung, K.H., Lee, S.T., Bahn, J.J., Kim, M., Lee, S.K., Roh, J.K., 2009.
Autophagyisinvolvedintheischemicpreconditioning.Neurosci.Lett.451,16–
19.
Parsons, J.T., Churn, S.B., DeLorenzo, R.J., 1997. Ischemia-induced inhibition of
calcium uptake into rat brain microsomes mediated by Mg2+/Ca2+ ATPase. J.
Neurochem. 68, 1124–1134.
Parsons, J.T., Churn, S.B., DeLorenzo, R.J., 1999. Global ischemia-induced inhibition
of the coupling ratio of calcium uptake and ATP hydrolysis by rat whole brain
microsomal Mg2+/Ca2+ ATPase. Brain Res. 834, 32–41.
Paschen, W., Aufenberg, C., Hotop, S., Mengesdorf, T., 2003. Transient cerebral
ischemia activates processing of xbp1 messenger RNA indicative of endoplasmic reticulum stress. J. Cereb. Blood Flow Metab. 23, 449–461.
Paschen, W., Gissel, C., Linden, T., Althausen, S., Doutheil, J., 1998. Activation of
gadd153 expression through transient cerebral ischemia: evidence that ischemia causes endoplasmic reticulum dysfunction. Brain Res. Mol. Brain Res. 60,
115–122.
Paschen, W., Mengesdorf, T., 2005. Endoplasmic reticulum stress response and
neurodegeneration. Cell Calcium 38, 409–415.
Patrick, G.N., Bingol, B., Weld, H.A., Schuman, E.M., 2003. Ubiquitin-mediated
proteasomeactivityisrequiredforagonist-inducedendocytosisofGluRs.Curr.
Biol. 13, 2073–2081.
Pavlopoulos,E., Trifilieff,P., Chevaleyre, V., Fioriti, L., Zairis, S., Pagano, A., Malleret,
G., Kandel, E.R., 2011. Neuralized1 activates CPEB3: a function for nonproteolyticubiquitininsynapticplasticityandmemorystorage.Cell147,1369–1383.
Peters, J.M., 2002. The anaphase-promoting complex: proteolysis in mitosis and
beyond. Mol. Cell 9, 931–943.
Peth, A., Besche, H.C., Goldberg, A.L., 2009. Ubiquitinated proteins activate the
proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol.
Cell 36, 794–804.
Peth, A., Kukushkin, N., Bosse, M., Goldberg, A.L., 2013. Ubiquitinated proteins
activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs. J.
Biol. Chem. 288, 7781–7790.
Petito,C.K.,Pulsinelli,W.A.,1984.Delayedneuronalrecoveryandneuronaldeathin
rat hippocampus following severe cerebral ischemia: possible relationship to
abnormalities in neuronal processes. J. Cereb. Blood Flow Metab. 4, 194–205.
Phillips, J.B., Williams, A.J., Adams, J., Elliott, P.J., Tortella, F.C., 2000. Proteasome
inhibitorPS519reducesinfarctionandattenuatesleukocyteinfiltrationinarat
model of focal cerebral ischemia. Stroke 31, 1686–1693.
Pickart, C.M., 2004. Back to the future with ubiquitin. Cell 116, 181–190.
Pottorf 2nd, W.J., Johanns, T.M., Derrington, S.M., Strehler, E.E., Enyedi, A.,
Thayer, S.A., 2006. Glutamate-induced protease-mediated loss of plasma
membrane Ca2+ pump activity in rat hippocampal neurons. J. Neurochem.
98, 1646–1656.
Pulsinelli,W.A.,Brierley,J.B.,Plum,F.,1982a.Temporal profileof neuronaldamage
in a model of transient forebrain ischemia. Ann. Neurol. 11, 491–498.
Pulsinelli, W.A., Levy, D.E., Duffy, T.E., 1982b. Regional cerebral blood flow and
glucose metabolism following transient forebrain ischemia. Ann. Neurol. 11,
499–502.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 67
(WITH PDF Extractor SDK TRIAL VERSION)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1125
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1130
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1130
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1130
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1135
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1140
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1140
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1145
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1145
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1150
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1150
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1150
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1155
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1155
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1155
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1160
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1160
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1165
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1170
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1175
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1175
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1180
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1180
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1185
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1185
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1190
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1195
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1195
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1195
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1200
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1205
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1205
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1215
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1215
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1215
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1220
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1225
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1225
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1230
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1230
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1230
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1235
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1235
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1240
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1245
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1250
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1255
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1255
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1260
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1265
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1265
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1270
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1270
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1275
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1280
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1280
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1280
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1285
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1285
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1290
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1295
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1295
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1300
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1300
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1305
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1305
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1305
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1310
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1310
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1315
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1315
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1320
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1325
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1325
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1325
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1330
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1330
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1335
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1335
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1340
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1340
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1345
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1345
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1350
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1355
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1355
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1355
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1360
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1360
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1360
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1365
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1365
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1365
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1370
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1370
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1375
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1380
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1380
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1385
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1390
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1395
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1395
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1400
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1400
Puram, S.V., Kim, A.H., Park, H.Y., Anckar, J., Bonni, A., 2013. The ubiquitin receptor
S5a/Rpn10 links centrosomal proteasomes with dendrite development in the
mammalian brain. Cell Rep. 4, 19–30.
Qiu,J.H.,Asai,A.,Chi,S.,Saito,N.,Hamada,H.,Kirino,T.,2000.Proteasomeinhibitors
induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured
cortical neurons. J. Neurosci. 20, 259–265.
Rehni, A.K., Singh, T.G., Behl, N., Arora, S., 2010. Possible involvement of ubiquitin
proteasome system and other proteases in acute and delayed aspects of
ischemic preconditioning of brain in mice. Biol. Pharm. Bull. 33, 1953–
1957.
Reinheckel, T., Sitte, N., Ullrich, O., Kuckelkorn, U., Davies, K.J., Grune, T., 1998.
Comparative resistance of the 20S and 26S proteasome to oxidative stress.
Biochem. J. 335 (Pt 3) 637–642.
Reits,E.A.,Benham,A.M.,Plougastel,B.,Neefjes,J.,Trowsdale,J.,1997.Dynamicsof
proteasome distribution in living cells. EMBO J. 16, 6087–6094.
Roberts, G.G., Di Loreto, M.J., Marshall, M., Wang, J., DeGracia, D.J., 2007. Hippocampal cellular stress responses after global brain ischemia and reperfusion.
Antioxid. Redox Signal. 9, 2265–2275.
Rock,K.L.,Gramm,C.,Rothstein,L.,Clark,K.,Stein,R.,Dick,L.,Hwang,D.,Goldberg,
A.L., 1994. Inhibitors of the proteasome block the degradation of most cell
proteins and the generation of peptides presented on MHC class I molecules.
Cell 78, 761–771.
Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B.,
Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Fullerton, H.J., Gillespie, C., Hailpern,
S.M., Heit, J.A., Howard, V.J., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman,
J.H., Lisabeth, L.D., Makuc, D.M., Marcus, G.M., Marelli, A., Matchar, D.B., Moy,
C.S., Mozaffarian, D., Mussolino, M.E., Nichol, G., Paynter, N.P., Soliman, E.Z.,
Sorlie,P.D.,Sotoodehnia,N.,Turan,T.N.,Virani,S.S.,Wong,N.D.,Woo,D.,Turner,
M.B., 2012. Heart disease and stroke statistics–2012 update: a report from the
American Heart Association. Circulation 125, e2–e220.
Rong, Y., Lu, X., Bernard, A., Khrestchatisky, M., Baudry, M., 2001. Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially
modulatestheirsusceptibilitytocalpainandenhancestheirbindingtospectrin
and PSD-95. J. Neurochem. 79, 382–390.
Rosenzweig,R.,Bronner,V.,Zhang,D.,Fushman,D.,Glickman,M.H.,2012.Rpn1and
Rpn2coordinateubiquitinprocessingfactorsatproteasome.J.Biol.Chem.287,
14659–14671.
Rossi,D.J.,Oshima,T.,Attwell,D.,2000.Glutamatereleaseinseverebrainischaemia
is mainly by reversed uptake. Nature 403, 316–321.
Roy, S., Sharom, J.R., Houde, C., Loisel, T.P., Vaillancourt, J.P., Shao, W., Saleh, M.,
Nicholson, D.W., 2008. Confinement of caspase-12 proteolytic activity to
autoprocessing. Proc. Natl. Acad. Sci. U.S.A. 105, 4133–4138.
Ruschak, A.M., Slassi, M., Kay, L.E., Schimmer, A.D., 2011. Novel proteasome inhibitorstoovercomebortezomibresistance.J.Natl.CancerInst.103,1007–1017.
Russell, S.J., Steger, K.A., Johnston, S.A., 1999. Subcellular localization, stoichiometry
, and protein levels of 26 S proteasome subunits in yeast. J. Biol. Chem. 274,
21943–21952.
Sakata, E., Bohn, S., Mihalache, O., Kiss, P., Beck, F., Nagy, I., Nickell, S., Tanaka, K.,
Saeki, Y., Forster, F., Baumeister, W., 2012. Localization of the proteasomal
ubiquitin receptors Rpn10 and Rpn13 by electron cryomicroscopy. Proc. Natl.
Acad. Sci. U.S.A. 109, 1479–1484.
Sanchez-Gomez,M.V.,Alberdi,E.,Perez-Navarro,E.,Alberch,J.,Matute,C.,2011.Bax
andcalpainmediateexcitotoxicoligodendrocytedeathinducedbyactivationof
both AMPA and kainate receptors. J. Neurosci. 31, 2996–3006.
Sattler, R., Tymianski, M., 2000. Molecular mechanisms of calcium-dependent
excitotoxicity. J. Mol. Med. (Berl.) 78, 3–13.
Schlesinger,D.H.,Goldstein,G.,Niall,H.D.,1975.Thecompleteaminoacidsequence
ofubiquitin,anadenylatecyclasestimulatingpolypeptideprobablyuniversalin
living cells. Biochemistry 14, 2214–2218.
Schreiner, P., Chen, X., Husnjak, K., Randles, L., Zhang, N.X., Elsasser, S., Finley, D.,
Dikic, I., Walters, K.J., Groll, M., 2008. Ubiquitin docking at the proteasome
through a novel pleckstrin-homology domain interaction. Nature 453, 548–
552.
Schubert, U., Anton, L.C., Gibbs, J., Norbury, C.C., Yewdell, J.W., Bennink, J.R., 2000.
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770–774.
Schwarz, L.A., Hall, B.J., Patrick, G.N., 2010. Activity-dependent ubiquitination of
GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway. J.
Neurosci. 30, 16718–16729.
Seibenhener, M.L., Babu, J.R., Geetha, T., Wong, H.C., Krishna, N.R., Wooten, M.W.,
2004.Sequestosome1/p62isapolyubiquitinchainbindingproteininvolvedin
ubiquitin proteasome degradation. Mol. Cell. Biol. 24, 8055–8068.
Seyfried,D.M.,Veyna,R.,Han,Y.,Li,K.,Tang,N.,Betts,R.L.,Weinsheimer,S.,Chopp,
M., Anagli, J., 2001. A selective cysteine protease inhibitor is non-toxic and
cerebroprotectiveinratsundergoingtransientmiddlecerebralarteryischemia.
Brain Res. 901, 94–101.
Shabek, N., Herman-Bachinsky, Y., Buchsbaum, S., Lewinson, O., Haj-Yahya, M.,
Hejjaoui,M.,Lashuel,H.A.,Sommer,T.,Brik,A.,Ciechanover,A.,2012.Thesizeof
theproteasomalsubstratedetermineswhetheritsdegradation willbemediated by mono- or polyubiquitylation. Mol. Cell 48, 87–97.
Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P., Honore, T., 1990. 2,3-
Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for
cerebral ischemia. Science 247, 571–574.
Sheng,R.,Liu,X.Q.,Zhang,L.S.,Gao,B.,Han,R.,Wu,Y.Q.,Zhang,X.Y.,Qin,Z.H.,2012.
Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning. Autophagy 8, 310–325.
Shibata,M.,Hattori,H.,Sasaki,T.,Gotoh,J.,Hamada,J.,Fukuuchi,Y.,2003.Activation
of caspase-12 by endoplasmic reticulum stress induced by transient middle
cerebral artery occlusion in mice. Neuroscience 118, 491–499.
Shih, A.Y., Blinder, P., Tsai, P.S., Friedman, B., Stanley, G., Lyden, P.D., Kleinfeld, D.,
2013. The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat. Neurosci. 16, 55–63.
Shin, S.M., Zhang, N., Hansen, J., Gerges, N.Z., Pak, D.T., Sheng, M., Lee, S.H., 2012.
GKAP orchestrates activity-dependent postsynaptic protein remodeling and
homeostatic scaling. Nat. Neurosci. 15, 1655–1666.
Simon, R.P., Swan, J.H., Griffiths, T., Meldrum, B.S., 1984. Blockade of N-methyl-D-
aspartate receptors may protect against ischemic damage in the brain. Science
226, 850–852.
Soundarapandian, M.M., Tu, W.H., Peng, P.L., Zervos, A.S., Lu, Y., 2005. AMPA
receptor subunit GluR2 gates injurious signals in ischemic stroke. Mol. Neurobiol. 32, 145–155.
Stanika,R.I.,Pivovarova,N.B.,Brantner,C.A.,Watts,C.A.,Winters,C.A.,Andrews,S.B.,
2009. Coupling diverse routes of calcium entry to mitochondrial dysfunction
and glutamate excitotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 9854–9859.
Stoehr, G., Schaab, C., Graumann, J., Mann, M., 2013. A SILAC-based approach
identifies substrates of caspase-dependent cleavage upon TRAIL-induced apoptosis. Mol. Cell. Proteomics 12, 1436–1450.
Sun,H.S.,Jackson,M.F.,Martin,L.J.,Jansen,K.,Teves,L.,Cui,H.,Kiyonaka,S.,Mori,Y.,
Jones, M., Forder, J.P., Golde, T.E., Orser, B.A., Macdonald, J.F., Tymianski, M.,
2009. Suppression of hippocampal TRPM7 protein prevents delayed neuronal
death in brain ischemia. Nat. Neurosci. 12, 1300–1307.
Sun,X.M.,Butterworth,M.,MacFarlane,M.,Dubiel,W.,Ciechanover,A.,Cohen,G.M.,
2004. Caspase activation inhibits proteasome function during apoptosis. Mol.
Cell 14, 81–93.
Taglialatela, G., Kaufmann, J.A., Trevino, A., Perez-Polo, J.R., 1998. Central nervous
systemDNAfragmentationinducedbytheinhibitionofnuclearfactorkappaB.
Neuroreport 9, 489–493.
Tai, H.C., Besche, H., Goldberg, A.L., Schuman, E.M., 2010. Characterization of the
Brain 26S Proteasome and its Interacting Proteins. Front. Mol. Neurosci. 3, 12.
Tajiri,S.,Oyadomari,S.,Yano,S.,Morioka,M.,Gotoh,T.,Hamada,J.I.,Ushio,Y.,Mori,
M.,2004.Ischemia-inducedneuronalcelldeathismediatedbytheendoplasmic
reticulum stress pathway involving CHOP. Cell Death Differ. 11, 403–415.
Takano,J.,Tomioka,M.,Tsubuki,S.,Higuchi,M.,Iwata,N.,Itohara,S.,Maki,M.,Saido,
T.C., 2005. Calpain mediates excitotoxic DNA fragmentation via mitochondrial
pathwaysinadultbrains:evidencefromcalpastatinmutantmice.J.Biol.Chem.
280, 16175–16184.
Tan, Y.Y., Zhou, H.Y., Wang, Z.Q., Chen, S.D., 2008. Endoplasmic reticulum stress
contributes to the cell death induced by UCH-L1 inhibitor. Mol. Cell. Biochem.
318, 109–115.
Tanaka,H.,Grooms,S.Y.,Bennett,M.V.,Zukin,R.S.,2000.TheAMPARsubunitGluR2:
still front and center-stage. Brain Res. 886, 190–207.
Tanaka, K., Yoshimura, T., Tamura, T., Fujiwara, T., Kumatori, A., Ichihara, A., 1990.
Possible mechanism of nuclear translocation of proteasomes. FEBS Lett. 271,
41–46.
Todi, S.V., Paulson, H.L., 2011. Balancing act: deubiquitinating enzymes in the
nervous system. Trends Neurosci. 34, 370–382.
Tomko Jr., R.J., Hochstrasser, M., 2013. Molecular architecture and assembly of the
eukaryotic proteasome. Annu. Rev. Biochem. 82, 415–445.
Truettner, J.S., Hu, K., Liu, C.L., Dietrich, W.D., Hu, B., 2009. Subcellular stress
response and induction of molecular chaperones and folding proteins after
transient global ischemia in rats. Brain Res. 1249, 9–18.
Tsai,N.P.,Wilkerson,J.R.,Guo,W.,Maksimova,M.A.,Demartino,G.N.,Cowan,C.W.,
Huber, K.M., 2012. Multiple Autism-linked genes mediate synapse elimination
via proteasomal degradation of a synaptic scaffold PSD-95. Cell 151, 1581–
1594.
Urban, P., Pavlikova, M., Sivonova, M., Kaplan, P., Tatarkova, Z., Kaminska, B.,
Lehotsky,J.,2009.Molecularanalysisofendoplasmicreticulumstressresponse
after global forebrain ischemia/reperfusion in rats: effect of neuroprotectant
simvastatin. Cell Mol. Neurobiol. 29, 181–192.
Vadhvani, M., Schwedhelm-Domeyer, N., Mukherjee, C., Stegmuller, J., 2013. The
centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration. PLoS One 8, e57530.
van Den Hurk, W.H., Willems, H.J., Bloemen, M., Martens, G.J., 2001. Novel frameshift mutations near short simple repeats. J. Biol. Chem. 276, 11496–11498.
van Deventer, S., Neefjes, J., 2010. The immunoproteasome cleans up after inflammation. Cell 142, 517–518.
von Mikecz, A., 2006. The nuclear ubiquitin–proteasome system. J. Cell Sci. 119,
1977–1984.
Waataja, J.J., Kim, H.J., Roloff, A.M., Thayer, S.A., 2008. Excitotoxic loss of postsynapticsitesisdistincttemporallyandmechanisticallyfromneuronaldeath.J.
Neurochem. 104, 364–375.
Wada, M., Kosaka, M., Saito, S., Sano, T., Tanaka, K., Ichihara, A., 1993. Serum
concentration and localization in tumor cells of proteasomes in patients with
hematologic malignancy and their pathophysiologic significance. J. Lab. Clin.
Med. 121, 215–223.
Wagner, S.A., Beli, P., Weinert, B.T., Nielsen, M.L., Cox, J., Mann, M., Choudhary, C.,
2011. A proteome-wide, quantitative survey of in vivo ubiquitylation sites
reveals widespread regulatory roles. Mol. Cell. Proteomics 10 , M111 013284.
Walters, B.J., Campbell, S.L., Chen, P.C., Taylor, A.P., Schroeder, D.G., Dobrunz, L.E.,
Artavanis-Tsakonas, K., Ploegh, H.L., Wilson, J.A., Cox, G.A., Wilson, S.M., 2008.
Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system
and synaptic activity. Mol. Cell. Neurosci. 39, 539–548.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 68
(EVAL PDF Extractor SDK 8.0.0.2542-699435451)
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1405
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1405
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1410
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1410
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1410
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1415
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1420
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1425
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1425
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1425
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1430
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1430
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1435
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1440
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1445
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1450
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1455
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1460
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1460
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1465
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1470
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1470
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1475
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1475
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1480
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1485
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1490
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1490
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1490
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1495
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1495
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1495
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1500
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1500
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1500
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1505
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1505
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1510
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1510
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1515
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1515
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1515
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1520
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1520
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1525
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1530
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1530
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1530
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1535
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1535
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1540
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1540
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1540
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1545
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1545
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1550
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1550
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1550
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1555
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1560
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1560
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1560
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1565
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1570
[Link]
http://refhub.elsevier.com/S0301-0082(13)00103-2/sbref1570
Wang, F., Durfee, L.A., Huibregtse, J.M., 2013. A cotranslational ubiquitination
pathway for quality control of misfolded proteins. Mol. Cell 50, 368–378.
Waung, M.W., Pfeiffer, B.E., Nosyreva, E.D., Ronesi, J.A., Huber, K.M., 2008. Rapid
translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through
persistent increases in AMPAR endocytosis rate. Neuron 59, 84–97.
Wei,G.,Yin,Y.,Li,W.,Bito,H.,She,H.,Mao,Z.,2012.Calpain-mediateddegradation
of myocyte enhancer factor 2D contributes to excitotoxicity by activation of
extrasynaptic N-methyl-D-aspartate receptors. J. Biol. Chem. 287, 5797–5805.
Weih,M.,Schmitt,M.,Gieche,J.,Harms, C.,Ruscher,K.,Dirnagl, U.,Grune,T.,2001.
Proteolysisofoxidizedproteinsafteroxygen-glucosedeprivationinratcortical
neurons is mediated bythe proteasome. J. Cereb. BloodFlow Metab. 21, 1090–
1096.
Wickliffe, K.E., Williamson, A., Meyer, H.J., Kelly, A., Rape, M., 2011. K11-linked
ubiquitin chains as novel regulators of cell division. Trends Cell Biol. 21, 656–
663.
Wigley, W.C., Fabunmi, R.P., Lee, M.G., Marino, C.R., Muallem, S., DeMartino, G.N.,
Thomas, P.J., 1999. Dynamic association of proteasomal machinery with the
centrosome. J. Cell Biol. 145, 481–490.
Wilkinson, K.D., Urban, M.K., Haas, A.L., 1980. Ubiquitin is the ATP-dependent
proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 255, 7529–7532.
Willeumier, K., Pulst, S.M., Schweizer, F.E., 2006. Proteasome inhibition triggers
activity-dependentincrease inthesizeof therecycling vesiclepoolincultured
hippocampal neurons. J. Neurosci. 26, 11333–11341.
Williams, A.J., Berti, R., Dave, J.R., Elliot, P.J., Adams, J., Tortella, F.C., 2004. Delayed
treatment of ischemia/reperfusion brain injury: extended therapeutic window
with the proteosome inhibitor MLN519. Stroke 35, 1186–1191.
Williams, A.J., Hale, S.L., Moffett, J.R., Dave, J.R., Elliott, P.J., Adams, J., Tortella, F.C.,
2003. Delayed treatment with MLN519 reduces infarction and associated
neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and
leukocyte infiltration. J. Cereb. Blood Flow Metab. 23, 75–87.
Williams, A.J., Myers, T.M., Cohn, S.I., Sharrow, K.M., Lu, X.C., Tortella, F.C., 2005.
Recovery from ischemic brain injury in the rat following a 10h delayed
injection with MLN519. Pharmacol. Biochem. Behav. 81, 182–189.
Williams, C.A., Driscoll, D.J., Dagli, A.I., 2010. Clinical and genetic aspects of Angelman syndrome. Genet. Med. 12, 385–395.
Wilson,S.M.,Bhattacharyya,B.,Rachel,R.A.,Coppola,V.,Tessarollo,L.,Householder,
D.B., Fletcher, C.F., Miller, R.J., Copeland, N.G., Jenkins, N.A., 2002. Synaptic
defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitinspecific protease. Nat. Genet. 32, 420–425.
Wroge,C.M.,Hogins,J.,Eisenman,L.,Mennerick,S.,2012.SynapticNMDAreceptors
mediate hypoxic excitotoxic death. J. Neurosci. 32, 6732–6742.
Xie, Y., 2010. Structure, assembly and homeostatic regulation of the 26S proteasome. J. Mol. Cell. Biol. 2, 308–317.
Xiong, Z.G., Zhu, X.M., Chu, X.P., Minami, M., Hey, J., Wei, W.L., MacDonald, J.F.,
Wemmie, J.A., Price, M.P., Welsh, M.J., Simon, R.P., 2004. Neuroprotection in
ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118,
687–698.
Xu, J., Kurup, P., Zhang,Y., Goebel-Goody,S.M., Wu, P.H.,Hawasli, A.H., Baum, M.L.,
Bibb, J.A., Lombroso, P.J., 2009a. Extrasynaptic NMDA receptors couple preferentiallytoexcitotoxicityviacalpain-mediatedcleavageofSTEP.J.Neurosci.29,
9330–9343.
Xu,P.,Duong,D.M.,Seyfried,N.T.,Cheng,D.,Xie,Y.,Robert,J.,Rush,J.,Hochstrasser,
M., Finley, D., Peng, J., 2009b. Quantitative proteomics reveals the function of
unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133–
145.
Yamashiro,K.,Liu,R.,Maeda,M.,Hattori,N.,Urabe,T.,2007.Inductionandselective
accumulation of mutant ubiquitin in CA1 pyramidal neurons after transient
global ischemia. Neuroscience 147, 71–79.
Yang, S.W., Oh, K.H., Park, E., Chang, H.M., Park, J.M., Seong, M.W., Ka, S.H., Song,
W.K.,Park,D.E.,Baas,P.W.,Jeon,Y.J.,Chung,C.H.,2013.USP47andCterminusof
Hsp70-interacting protein (CHIP) antagonistically regulate katanin-p60-mediated axonal growth. J. Neurosci. 33, 12728–12738.
Yang, Z., Klionsky, D.J., 2009. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 335, 1–32.
Ye,Y.,Rape,M.,2009.Buildingubiquitinchains:E2enzymesatwork.Nat.Rev.Mol.
Cell. Biol. 10, 755–764.
Ye, Z.C., Wyeth, M.S., Baltan-Tekkok, S., Ransom, B.R., 2003. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 23,
3588–3596.
Yi, J.J., Ehlers, M.D., 2007. Emerging roles for ubiquitin and protein degradation in
neuronal function. Pharmacol. Rev. 59, 14–39.
Yoshida, H., Haze, K., Yanagi, H., Yura, T., Mori, K., 1998. Identification of the cisacting endoplasmic reticulum stress response element responsible for transcriptionalinductionofmammalianglucose-regulatedproteins.Involvementof
basic leucine zipper transcription factors. J. Biol. Chem. 273, 33741–33749.
Yuen, E.Y., Liu, W., Yan, Z., 2007. The phosphorylation state of GluR1 subunits
determines the susceptibility of AMPA receptors to calpain cleavage. J. Biol.
Chem. 282, 16434–16440.
Zhang, F., Liu, C.L., Hu, B.R., 2006a. Irreversible aggregation of protein synthesis
machinery after focal brain ischemia. J. Neurochem. 98, 102–112.
Zhang,L.,Zhang,Z.G.,Buller,B.,Jiang,J.,Jiang,Y.,Zhao,D.,Liu,X.,Morris,D.,Chopp,
M., 2010. Combination treatment withVELCADE and low-dose tissue plasminogenactivatorprovidespotentneuroprotectioninagedratsafterembolicfocal
ischemia. Stroke 41, 1001–1007.
Zhang, L., Zhang, Z.G., Liu, X., Hozeska, A., Stagliano, N., Riordan, W., Lu, M., Chopp,
M., 2006b. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Thromb. Haemost. 95, 166–173.
Zhang, L., Zhang, Z.G., Zhang, R.L., Lu, M., Adams, J., Elliott, P.J., Chopp, M., 2001.
Postischemic(6-Hour)treatmentwithrecombinanthumantissueplasminogen
activator and proteasome inhibitor PS-519 reduces infarction in a rat model of
embolic focal cerebral ischemia. Stroke 32, 2926–2931.
Zhang, Q.G., Xu, Y.L., Li, H.C., Han, D., Zhang, G.Y., 2006c. NMDA receptor/L-VGCC-
dependent expression and AMPA/KA receptor-dependent activation of
c-Jun induced by cerebral ischemia in rat hippocampus. Neurosci. Lett. 398,
268–273.
Zhang,X.,Yan,H.,Yuan,Y.,Gao,J.,Shen,Z.,Cheng,Y.,Shen,Y.,Wang,R.R.,Wang,X.,
Hu, W.W., Wang, G., Chen, Z., 2013a. Cerebral ischemia-reperfusion-induced
autophagyprotectsagainstneuronalinjurybymitochondrialclearance.Autophagy 9, 1321–1333.
Zhang,Y.,Zhou,L.,Rouge,L.,Phillips,A.H.,Lam,C.,Liu,P.,Sandoval,W.,Helgason,E.,
Murray, J.M., Wertz, I.E., Corn, J.E., 2013b. Conformational stabilization of
ubiquitin yields potent and selective inhibitors of USP7. Nat. Chem. Biol. 9,
51–58.
Ziv, I., Matiuhin, Y., Kirkpatrick, D.S., Erpapazoglou, Z., Leon, S., Pantazopoulou, M.,
Kim,W., Gygi,S.P., Haguenauer-Tsapis, R., Reis, N., Glickman,M.H.,Kleifeld, O.,
2011. A perturbed ubiquitin landscape distinguishes between ubiquitin in
trafficking and in proteolysis. Mol. Cell. Proteomics 10 , M111 009753.
M.V. Caldeira et al./Progress in Neurobiology 112 (2014) 50–69 69
(PDF Extractor SDK TRIAL VERSION)
